index	sentence	label
0	@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1
1	Calcium-dependent Cl (-) currents were activated by @COMPOUND$ in HEK293 cells expressing @PROTEIN$.	0
2	Calcium-dependent @COMPOUND$ (-) currents were activated by ATP in HEK293 cells expressing @PROTEIN$.	0
3	The absorption spectrum of the @PROTEIN$ enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-@COMPOUND$ clusters.	1
4	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and @PROTEIN$ activation.	1
5	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-@PROTEIN$/FE65 nuclear translocation and GSK3 beta activation.	1
6	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/@PROTEIN$ nuclear translocation and GSK3 beta activation.	1
7	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0
8	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0
9	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
10	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
11	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
12	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of cholesterol and @COMPOUND$.	1
13	The scavenger receptor, class B, type I (@PROTEIN$) is critical in maintaining the homeostasis of @COMPOUND$ and alpha-tocopherol.	1
14	SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0
15	@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1
16	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0
17	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0
18	@COMPOUND$ is believed to confer its diabetogenic effect by inhibiting pancreatic @PROTEIN$ activity, leading to pancreatic beta-cell death.	1
19	Although @PROTEIN$4 has been repeatedly associated with altered sphingomyelin and @COMPOUND$ levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.	1
20	Here we show that during growth in media containing @COMPOUND$ and in complex medium without glucose RamB activates expression of the @PROTEIN$ gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	0
21	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
22	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
23	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
24	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
25	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
26	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
27	@COMPOUND$ (NAA) is converted into aspartate and acetate by @PROTEIN$.	1
28	N-acetylaspartic acid (NAA) is converted into @COMPOUND$ and acetate by @PROTEIN$.	1
29	N-acetylaspartic acid (NAA) is converted into aspartate and @COMPOUND$ by @PROTEIN$.	1
30	In addition, treatment with @COMPOUND$ increased interleukin-4 (@PROTEIN$) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.	1
31	Serum @PROTEIN$ levels were increased and plasma levels of @COMPOUND$ and MHPG were decreased according to the recovery from the active phase of the disease.	0
32	Serum @PROTEIN$ levels were increased and plasma levels of HVA and @COMPOUND$ were decreased according to the recovery from the active phase of the disease.	0
33	These results suggest that dysfunctions of catecholaminergic neurons and @PROTEIN$ might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to @COMPOUND$ might be associated with the improvement of the disease.	0
34	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
35	@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1
36	Selenium and @COMPOUND$ levels were not associated to @PROTEIN$ Abeta42.	0
37	In vitro, the degradation of synthetic Abeta substrate added to @PROTEIN$ was markedly accelerated by low levels (2microM) of exogenous zinc and @COMPOUND$.	1
38	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
39	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
40	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of spermidine and @COMPOUND$ were significantly decreased, while putrescine concentration was significantly increased.	1
41	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of spermidine and spermine were significantly decreased, while @COMPOUND$ concentration was significantly increased.	1
42	It was found that the expression of @PROTEIN$ and ODC were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
43	It was found that the expression of SSAT and @PROTEIN$ were upregulated after reperfusion and the concentrations of @COMPOUND$ and spermine were significantly decreased, while putrescine concentration was significantly increased.	1
44	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/@PROTEIN$ (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
45	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (APP)/presenilin-1 (@PROTEIN$) double transgenic mouse model of Alzheimer's disease (AD).	0
46	In the present study, we investigated the effects of @COMPOUND$ on memory impairment and pathological changes in an amyloid precursor protein (@PROTEIN$)/presenilin-1 (PS-1) double transgenic mouse model of Alzheimer's disease (AD).	0
47	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
48	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
49	Furthermore, @COMPOUND$ attenuated anxiety-like behavior, up-regulated cerebral @PROTEIN$ protein, and decreased cerebral nitrotyrosine in the transgenic mice.	1
50	@COMPOUND$ rapidly phosphorylated Akt and endothelial @PROTEIN$ (eNOS) in human endothelial cells.	1
51	@COMPOUND$ rapidly phosphorylated Akt and endothelial nitric oxide synthase (@PROTEIN$) in human endothelial cells.	1
52	@COMPOUND$ rapidly phosphorylated @PROTEIN$ and endothelial nitric oxide synthase (eNOS) in human endothelial cells.	1
53	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of Akt and @PROTEIN$.	1
54	Our findings indicate that @COMPOUND$ protects endothelial cells from death with phosphorylation of @PROTEIN$ and eNOS.	1
55	@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1
56	The long pentraxin 3 (@PROTEIN$) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of @COMPOUND$-rich extracellular matrices.	1
57	Several studies have shown that epsilon 2 carriers have lower low-density lipoprotein and apo B levels and higher @PROTEIN$ @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
58	Several studies have shown that @PROTEIN$ 2 carriers have lower low-density lipoprotein and apo B levels and higher high-density lipoprotein @COMPOUND$ and apo A-I levels than epsilon 3 carriers.	1
59	Toxicity and characterization of @PROTEIN$-inhibition induced by @COMPOUND$ in Artemia salina larvae.	1
60	Serum adipocyte @PROTEIN$ levels in patients with type 2 diabetes mellitus and obesity: the influence of @COMPOUND$ treatment.	0
61	Serum @PROTEIN$ levels were 2.5-fold higher in T2DM group relative to C and were not affected by @COMPOUND$ treatment (C: 20.6+/-2.1 microg/l, T2DM before F: 55.6+/-5.7 microg/l, T2DM after F: 54.2+/-5.4 microg/l, p 0.0001 for C vs. T2DM before F).	0
62	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated @PROTEIN$, atherogenic index and insulin levels.	0
63	@PROTEIN$ levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and insulin levels.	1
64	FABP levels positively correlated with BMI, triglyceride levels, blood @COMPOUND$, glycated hemoglobin, atherogenic index and @PROTEIN$ levels.	0
65	@COMPOUND$ enemas upregulate @PROTEIN$ genes expression but decrease adherent mucus thickness in mice colon.	1
66	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1
67	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1
68	@COMPOUND$ especially induced a 6-fold increase in @PROTEIN$ gene expression in proximal colon.	1
69	However, @COMPOUND$ enemas did not modify the number of epithelial cells containing the protein @PROTEIN$, and caused a 2-fold decrease in the thickness of adherent mucus layer.	0
70	However, we also observed that @COMPOUND$ (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced @PROTEIN$ expression in breast cancer cells.	1
71	Expression of senescence-associated beta-galactosidase (SA-beta-@PROTEIN$) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
72	Expression of senescence-associated @PROTEIN$ (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
73	It has been shown that the removal efficiency of @PROTEIN$ increased with the increasing applied current density and increasing PAC and @COMPOUND$ (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.	1
74	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
75	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of ornithine decarboxylase to the same extent, but had no effect on @PROTEIN$ activity.	0
76	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
77	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of lysine decarboxylase and of @PROTEIN$ to the same extent, but had no effect on arginine decarboxylase activity.	1
78	In the root soluble fraction, the suicide inhibitor alpha-@COMPOUND$-lysine suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
79	In the root soluble fraction, the suicide inhibitor alpha-difluoromethyl-@COMPOUND$ suppressed the activity of @PROTEIN$ and of ornithine decarboxylase to the same extent, but had no effect on arginine decarboxylase activity.	1
80	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
81	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
82	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
83	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
84	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
85	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
86	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
87	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
88	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
89	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
90	In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on @COMPOUND$ supplementation in order to evaluate the experimental evidence and the effects of age and chronic immobility on responses of parathyroid hormone (@PROTEIN$).	1
91	The @COMPOUND$ supplementation of the chronically immobile patients resulted in a smaller decrease in @PROTEIN$ 0.001).	1
92	Our results also suggest that @PROTEIN$ decreases quite linearly during @COMPOUND$ supplementation at any given 25-OHD level.	1
93	@PROTEIN$ did not show any effect in long photoperiod but decreased proliferation by stimulating @COMPOUND$ in short photoperiod.	1
94	To compare the changes in body composition and in @PROTEIN$ levels in postmenopausal women receiving hormone therapy (HT) or @COMPOUND$.	1
95	Common 677C--&gt;T mutation of the @PROTEIN$ gene affects follicular @COMPOUND$ synthesis.	1
96	Furthermore, the suppressive effects of P on @PROTEIN$ release and caspase-9 and caspase-3 activation in serum-deprived MC3T3-E1 cells were also reversed by @COMPOUND$.	1
97	Therapeutic @COMPOUND$/@PROTEIN$ activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	1
98	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (VEGF) in an @PROTEIN$ dependent manner; while the ERalpha positive MCF-7 cells did not.	1
99	However, when ERalpha negative MDA-MB-435 cells were treated with @COMPOUND$, they demonstrated increased expression of vascular endothelial growth factor (@PROTEIN$) in an AMPK dependent manner; while the ERalpha positive MCF-7 cells did not.	1
100	The @COMPOUND$-treated group showed increased @PROTEIN$ expression, intratumoral microvascular density and reduced necrosis.	1
101	@COMPOUND$ treatment was sufficient, however, to reduce systemic @PROTEIN$ and the proliferation rate of tumor cells in vascularized regions.	1
102	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
103	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
104	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
105	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
106	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
107	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
108	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
109	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
110	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
111	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
112	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
113	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
114	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
115	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
116	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
117	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
118	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
119	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
120	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
121	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
122	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
123	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
124	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
125	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
126	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
127	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
128	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
129	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
130	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
131	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
132	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, @PROTEIN$, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
133	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
134	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
135	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
136	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, @COMPOUND$, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
137	@PROTEIN$, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
138	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, @COMPOUND$, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
139	TNF-alpha, @PROTEIN$, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
140	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
141	TNF-alpha, MCP-1, MIP-1alpha, IL-8, @PROTEIN$, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, @COMPOUND$, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
142	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, @PROTEIN$, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
143	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, @PROTEIN$, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
144	TNF-alpha, MCP-1, MIP-1alpha, @PROTEIN$, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
145	TNF-alpha, MCP-1, @PROTEIN$, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and IL-10 were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of 2-hydroxyethyl methacrylate, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture @COMPOUND$ (TCPS) plates.	0
146	TNF-alpha, MCP-1, MIP-1alpha, IL-8, IL-6, IL-1beta, VEGF, IL-1ra, and @PROTEIN$ were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, polyurethane, expanded polytetrafluoroethylene, polymethyl methacrylate, and a hydrogel copolymer of @COMPOUND$, 1-vinyl-2-pyrrolidinone, and polyethylene glycol acrylate in tissue culture polystyrene (TCPS) plates.	0
147	At the time, @PROTEIN$ activity was significantly inhibited and gamma-glutamyl @COMPOUND$ increased by ACA exposure.	0
148	The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
149	The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
150	Increased @COMPOUND$ tone and decreased @PROTEIN$ concentrations may also contribute to reduced GH levels.	0
151	Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0
152	) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1
153	) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1
154	) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1
155	) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1
156	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
157	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
158	Since @COMPOUND$ is metabolized through @PROTEIN$, we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.	1
159	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/Bax ratio and reduction of @PROTEIN$ IV activity.	0
160	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/@PROTEIN$ ratio and reduction of COX IV activity.	0
161	Peripheral venous levels of @COMPOUND$, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
162	Peripheral venous levels of testosterone, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), @COMPOUND$ and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
163	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of @COMPOUND$ (LPS) and @PROTEIN$.	0
164	@PROTEIN$ and two additional catalase isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
165	MnSOD and two additional @PROTEIN$ isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
166	@PROTEIN$ and two additional catalase isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
167	MnSOD and two additional @PROTEIN$ isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
168	Results indicate that @PROTEIN$ has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas SOD could be critical.	1
169	Results indicate that catalase has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas @PROTEIN$ could be critical.	1
170	Results indicate that @PROTEIN$ has a much weakly role in the defense against quinclorac or @COMPOUND$ induced oxidative stress, whereas SOD could be critical.	1
171	Results indicate that catalase has a much weakly role in the defense against @COMPOUND$ or bensulfuron-methyl induced oxidative stress, whereas @PROTEIN$ could be critical.	1
172	SMC cultured on P(100/0) films modified by covalently attached @PROTEIN$ or fibrin layers proliferated at a rate comparable to that observed on control tissue culture @COMPOUND$.	0
173	However, prewetting P(70/30) with a @COMPOUND$ buffer prior to aminolysis significantly improved cell numbers following immobilization of @PROTEIN$.	0
174	Our data suggest HumDN1 genotypes are related to total @COMPOUND$ levels in Han Chinese MI patients, but @PROTEIN$ gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	0
175	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative @PROTEIN$ of cell-surface fatty acid genes.	1
176	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of @PROTEIN$, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.	1
177	Degradation analysis over 8 weeks in the presence of 10 mg/L @PROTEIN$ showed a 50% decrease in total weight and an 80% decrease in @COMPOUND$ molecular weight.	1
178	Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced @COMPOUND$+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/@PROTEIN$/2 pathway as demonstrated by Western blot analysis.	1
179	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
180	The role of phosphorylated @PROTEIN$ (p-Akt) in oral carcinogenesis induced by @COMPOUND$ and alkaline environments was investigated.	0
181	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (@PROTEIN$), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG).	0
182	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Müllerian hormone (AMH), @COMPOUND$, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (@PROTEIN$).	0
183	In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
184	In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
185	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
186	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
187	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
188	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
189	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
190	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
191	No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0
192	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1
193	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1
194	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1
195	Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0
196	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
197	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
198	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0
199	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
200	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
201	Because @PROTEIN$ binds @COMPOUND$, this study is using this feature to select functional spermatozoa.	1
202	In women, @PROTEIN$ levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and @COMPOUND$ level.	0
203	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
204	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
205	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
206	Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing @PROTEIN$, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist @COMPOUND$-AAM077.	1
207	Intracellular oxidative status was assessed by analysis of @COMPOUND$/GSSG levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
208	Intracellular oxidative status was assessed by analysis of GSH/@COMPOUND$ levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
209	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
210	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
211	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
212	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1
213	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and @PROTEIN$.	0
214	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and @PROTEIN$ was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1
215	Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in hyaluronic acid-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, @COMPOUND$, and BMP-2.	1
216	Real-time RT-PCR showed that the expression of osteoblast marker genes such as CBFalpha1 and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and @PROTEIN$.	0
217	Real-time RT-PCR showed that the expression of osteoblast marker genes such as @PROTEIN$ and alkaline phosphatase was increased in @COMPOUND$-based hydrogel, and the expression level was dependent on the molecular weight of hyaluronic acid, RGD peptide, and BMP-2.	1
218	The non-covalent interaction of @COMPOUND$ (BR) with @PROTEIN$ was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	1
219	Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0
220	Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1
221	) and two @COMPOUND$ tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and @PROTEIN$ production from days 8 to 11 post-insemination.	0
222	In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1
223	Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1
224	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, @COMPOUND$ (HA), @PROTEIN$, and decorin in the lamina propria of the scarred vocal folds.	0
225	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, @PROTEIN$, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
226	Histologic examination investigated deposition of extracellular matrix (@PROTEIN$) including collagen, elastin, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
227	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
228	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
229	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
230	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0
231	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0
232	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
233	In-vitro regeneration of @COMPOUND$ inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing xylene linker.	1
234	In-vitro regeneration of sarin inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing @COMPOUND$ linker.	1
235	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, sarin.	0
236	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, @COMPOUND$.	0
237	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, sarin.	0
238	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, @COMPOUND$.	0
239	Among the synthesized compounds, alpha,alpha'xylene-bis-(3,3'-(hydroxyiminomethyl) pyridinium) dibromide (3b) was found to be most potent reactivator for @PROTEIN$ inhibited by @COMPOUND$.	1
240	Of the compounds synthesized, @COMPOUND$, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-@PROTEIN$ with an IC(50) value of 2.81+/-1.26 microM, which is ca.	1
241	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0
242	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
243	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
244	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
245	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as @COMPOUND$ and its metabolite A771726 (teriflunomide).	1
246	Earlier publications have suggested a possible role for the efflux transporter @PROTEIN$ (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite A771726 (@COMPOUND$).	1
247	Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (@PROTEIN$) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its metabolite @COMPOUND$ (teriflunomide).	1
248	Inhibition of @PROTEIN$ by zebularine enhances the antineoplastic action of @COMPOUND$.	0
249	Inhibition of @PROTEIN$ by @COMPOUND$ enhances the antineoplastic action of 5-aza-2'-deoxycytidine.	1
250	An individual's response to @COMPOUND$ may be influenced by the amount of @PROTEIN$ (+) and CD8(+) T-lymphocyte suppression.	1
251	We hypothesise that @COMPOUND$ acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in @PROTEIN$ mutations with mild phenotypes.	0
252	We observed that @COMPOUND$ inhibited the proteasome activities and increased the level and insolubility of different @PROTEIN$ species, including phosphorylated tau.	1
253	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1
254	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1
255	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
256	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
257	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
258	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
259	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
260	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
261	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
262	However, increased blood @COMPOUND$ (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for @PROTEIN$.005; 48% for P-selectin, P=NS).	0
263	The expressions of @PROTEIN$ mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by @COMPOUND$ treatment.	1
264	In conclusion, @COMPOUND$ may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of @PROTEIN$ in the local kidney and the urinary excretion of MCP-1.	1
265	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0
266	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0
267	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0
268	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0
269	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
270	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
271	Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated @PROTEIN$ levels and rendered cells refractory to IGF-I stimulation.	1
272	Treating MCF-7 cells with @COMPOUND$-1642 Qdots, but not unconjugated Qdots alone, downregulated IGF1R levels and rendered cells refractory to @PROTEIN$ stimulation.	1
273	Our data suggest that @COMPOUND$-1642 Qdots can be used to detect @PROTEIN$ expression and measure changes in cell surface receptor levels.	1
274	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0
275	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1
276	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in quercetin content relative to @COMPOUND$ in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
277	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in @COMPOUND$ relative to kaempferol in leaf tissues, indicating that sequence-specific mRNA degradation of the @PROTEIN$ gene was induced.	0
278	Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, @COMPOUND$ and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1
279	Polyhydroxy phenolic compounds, such as flavonoids, @COMPOUND$, rosmarinic acid and aristolochic acid, are able to inhibit @PROTEIN$ (2) from different sources.	1
280	Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and @COMPOUND$, are able to inhibit @PROTEIN$ (2) from different sources.	1
281	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
282	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
283	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
284	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
285	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
286	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
287	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
288	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
289	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
290	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
291	Prediction of @PROTEIN$ receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	1
292	Quantitative structure-activity relationship (QSAR) models were developed to predict for @PROTEIN$ binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas using linear free energy relationship (LFER).	1
293	We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1
294	@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
295	@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
296	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
297	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
298	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
299	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
300	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
301	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
302	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (@COMPOUND$) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
303	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-@COMPOUND$ (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
304	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
305	Packed cell volume, total protein, creatinine, blood @COMPOUND$ nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
306	Packed cell volume, total protein, creatinine, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum @COMPOUND$ concentration increased.	0
307	Packed cell volume, total protein, creatinine, blood urea @COMPOUND$, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
308	Packed cell volume, total protein, @COMPOUND$, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
309	mRNA and protein levels of @PROTEIN$, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
310	mRNA and protein levels of TNF-alpha, @PROTEIN$, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
311	In addition, @COMPOUND$ treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of @PROTEIN$ in hepa1c1c 7 cells.	1
312	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating @PROTEIN$ and inhibiting the expression of Bcl-2.	1
313	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of @PROTEIN$.	1
314	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
315	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic @COMPOUND$ levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (@PROTEIN$).	0
316	In fact, hepatic @COMPOUND$ levels were significantly increased in the group of mice receiving the probiotic, and the increased @PROTEIN$ expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	1
317	Furthermore, supplementation of specific inhibitors of @PROTEIN$, C4H and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
318	Furthermore, supplementation of specific inhibitors of PAL, C4H and @PROTEIN$ in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
319	Furthermore, supplementation of specific inhibitors of PAL, @PROTEIN$ and 4CL in elicited cell cultures led to suppressed accumulation of @COMPOUND$, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	1
320	Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
321	Imatinib is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
322	@COMPOUND$ is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
323	@COMPOUND$ is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
324	@COMPOUND$ is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
325	Imatinib is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
326	In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1
327	The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
328	The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
329	There is clear evidence for TREK-1 and @PROTEIN$-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1
330	There is clear evidence for @PROTEIN$-1 and TASK-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, @COMPOUND$, pH, and neurotransmitters.	1
331	@PROTEIN$-1 may also have a critical role in mediating the vasodilator response of resistance arteries to @COMPOUND$, thus contributing to their protective effect on the cardiovascular system.	1
332	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, @PROTEIN$-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
333	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of @PROTEIN$-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line.	0
334	Alumina ceramic particles, in comparison with @COMPOUND$ particles, hardly affect the expression of RANK-, TNF-alpha-, and @PROTEIN$-mRNA in the THP-1 human monocytic cell line.	0
335	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
336	Three proteins, porcine somatotropin, bovine @PROTEIN$, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
337	Three proteins, porcine @PROTEIN$, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
338	The recombinant protein exhibited high @PROTEIN$ activity and could catalyze the conversion of L:-Phe to @COMPOUND$.	0
339	An alpha-numeric code for representing N-linked @COMPOUND$ structures in secreted @PROTEIN$.	1
340	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1
341	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
342	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
343	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
344	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
345	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
346	Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine @PROTEIN$ is one salutary mechanism underlying how @COMPOUND$ influences post-MI remodelling and thus improves LV function.	1
347	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of @PROTEIN$ (monocyte chemoattractant protein-1) and kidney cortex MCP-1 gene expression.	1
348	In addition, @COMPOUND$ treatment attenuated macrophage infiltration and inhibited urinary excretion of MCP-1 (@PROTEIN$) and kidney cortex MCP-1 gene expression.	1
349	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
350	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
351	Genetic variation in @PROTEIN$ (cholesteryl ester transfer protein) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1
352	Genetic variation in CETP (@PROTEIN$) has been clearly associated with HDL @COMPOUND$ levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	1
353	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
354	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
355	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and @PROTEIN$, B23).	0
356	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, @PROTEIN$ and nucleophosmin, B23).	0
357	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and nucleophosmin, @PROTEIN$).	0
358	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
359	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
360	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
361	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
362	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
363	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
364	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
365	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by proline and @COMPOUND$ under salt stress.	1
366	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (@PROTEIN$).	0
367	To decrease the level of androgen @COMPOUND$ in the prostate, we are interested in developing inhibitors of @PROTEIN$ (17beta-HSD5).	0
368	A role for guanosine 3',5'-cyclic monophosphate (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic @COMPOUND$ release.	0
369	A role for @COMPOUND$ (cGMP) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
370	A role for guanosine 3',5'-cyclic monophosphate (@COMPOUND$) and the @PROTEIN$ G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of (cGMP) result in short-term depression (STD) coupled with a reduction in presynaptic glutamate release.	0
371	Application of an inhibitor of soluble guanylate @PROTEIN$ prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-STD elicited in the presence of @COMPOUND$.	0
372	Application of an inhibitor of soluble guanylate cyclase prevented LTD induced by low-frequency stimulation (LFS), and impaired LFS-@PROTEIN$ elicited in the presence of @COMPOUND$.	1
373	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and @COMPOUND$ residues from a number of glycoconjugates.	1
374	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound @COMPOUND$ and N-acetylgalactosamine residues from a number of glycoconjugates.	1
375	Overexpression of @PROTEIN$ induces HepG2 cells death by the AMP kinase activator @COMPOUND$ (AICAR).	1
376	@COMPOUND$ induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and @PROTEIN$-independent mechanism.	1
377	In androgen-independent PC-3 cells, @COMPOUND$ also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially @PROTEIN$ dependent.	1
378	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
379	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
380	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of @PROTEIN$ and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
381	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-@PROTEIN$ and TGF-beta1, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
382	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and @PROTEIN$, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
383	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and @PROTEIN$, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
384	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
385	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1
386	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1
387	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
388	The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
389	The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
390	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
391	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
392	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
393	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
394	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
395	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
396	Prior to @COMPOUND$ supplementation, exercise induced a significant decrease in @PROTEIN$ activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
397	Prior to vitamin E supplementation, exercise induced a significant decrease in @PROTEIN$ activity, @COMPOUND$, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
398	After a 10 week vitamin E supplementation period, these exercise-induced changes in @PROTEIN$ activity, @COMPOUND$ and MDA concentration were still significant in the control group, but not in the supplemented group.	0
399	After a 10 week @COMPOUND$ supplementation period, these exercise-induced changes in @PROTEIN$ activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.	1
400	The model was used to investigate how on-treatment @PROTEIN$ related to baseline CRP and estimated treatment effects with @COMPOUND$.	1
401	Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1
402	Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0
403	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
404	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
405	Organic cations (@COMPOUND$) are primarily excreted via vectorial transport by various renal organic cation transporters (@PROTEIN$).	1
406	In a rat ARF model, induction of ARF by @COMPOUND$ (UN) treatment significantly decreased the levels of @PROTEIN$ (slc22a2) mRNA and protein in the kidney medulla.	1
407	In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1
408	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the P2Y12-@PROTEIN$ receptor gene.	1
409	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the @PROTEIN$-ADP receptor gene.	1
410	@COMPOUND$ up-regulates and activates @PROTEIN$-zeta in EBV-infected and EBV-transformed human B-cells.	1
411	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
412	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
413	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1
414	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), @PROTEIN$ (COX-2) and the transcription factor NF-kappaB.	1
415	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits @PROTEIN$ (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
416	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (@PROTEIN$), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB.	1
417	@COMPOUND$ (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (@PROTEIN$) and the transcription factor NF-kappaB.	1
418	Pigs fed the high-@COMPOUND$ diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
419	Pigs fed the high-lysine diet moreover had an increased concentration of @COMPOUND$ (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
420	Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of @COMPOUND$ (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
421	@COMPOUND$ attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced @PROTEIN$ activation.	1
422	@COMPOUND$ attenuates @PROTEIN$-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation.	1
423	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1
424	Collectively, our findings suggested that the inhibition of JNK and @PROTEIN$ activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
425	Collectively, our findings suggested that the inhibition of @PROTEIN$ and p38 activation interrupts CD40 induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
426	Collectively, our findings suggested that the inhibition of JNK and p38 activation interrupts @PROTEIN$ induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of @COMPOUND$ and its athero-protective function.	1
427	Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1
428	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
429	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
430	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
431	@COMPOUND$, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
432	Curcumin, demethoxycurcumin and @COMPOUND$ differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
433	Curcumin, @COMPOUND$ and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and @PROTEIN$.	1
434	@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1
435	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
436	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
437	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
438	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
439	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
440	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
441	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
442	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
443	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
444	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
445	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
446	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
447	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
448	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
449	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
450	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
451	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
452	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
453	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
454	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
455	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
456	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
457	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), @PROTEIN$ (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
458	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), @PROTEIN$ (GR) and @COMPOUND$ (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
459	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (GSH) were significantly diminished in DMH 0.05) elevated on simultaneous @COMPOUND$ supplementation.	1
460	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST), glutathione peroxidase (GPx), glutathione reductase (GR) and reduced glutathione (@COMPOUND$) were significantly diminished in DMH 0.05) elevated on simultaneous morin supplementation.	0
461	Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the @PROTEIN$ promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
462	Using in vitro binding assays we have demonstrated that @PROTEIN$, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
463	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
464	@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1
465	@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1
466	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
467	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
468	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
469	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
470	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
471	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
472	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
473	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
474	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
475	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
476	Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma @COMPOUND$ and advanced glycation end-product concentrations, increased parasympathetic tone, and increased @PROTEIN$ production.	0
477	cDNA probes have been developed for subsequent use in monitoring the @COMPOUND$ exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using @PROTEIN$ (MT) gene expression in different tissues of these species.	0
478	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
479	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
480	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
481	@COMPOUND$ could selectively inhibited @PROTEIN$ expression and PGE2 production.	1
482	Celecoxib could selectively inhibited @PROTEIN$ expression and @COMPOUND$ production.	0
483	@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
484	@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
485	@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
486	@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
487	It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1
488	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the @COMPOUND$ treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	1
489	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic @COMPOUND$ content exhibited the negative effect.	1
490	In addition, the levels of hepatic total protein, @COMPOUND$ and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	0
491	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
492	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
493	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
494	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
495	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
496	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
497	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
498	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
499	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
500	Effect of small interference RNA targeting @PROTEIN$ mediated by rAAV combined @COMPOUND$ on pancreatic tumors in athymic mice.	0
501	The increase of @COMPOUND$ was accompanied by a marked posttranslational down-regulation of liver @PROTEIN$ expression.	0
502	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving @PROTEIN$.	0
503	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of @PROTEIN$ in mouse liver via a mechanism likely involving PDZK1.	1
504	A 5.5 kilobase-pair (kbp) @PROTEIN$-Kpn1 fragment containing gene(s) encoding for @COMPOUND$ degradation was cloned.	1
505	From these findings, it is suggested that @COMPOUND$ may produce centrally mediated behavioural signs by increasing the ACh levels in the brain, resulting from its @PROTEIN$ and BuChE inhibitions.	1
506	Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
507	Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
508	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
509	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
510	However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0
511	However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0
512	These data indicate that @COMPOUND$ reduces intratesticular activity of @PROTEIN$ (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
513	These data indicate that @COMPOUND$ reduces intratesticular activity of COX-2 (as indicated by @PROTEIN$ (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
514	These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1
515	Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1
516	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0
517	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0
518	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
519	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
520	Plasma @PROTEIN$ 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma @COMPOUND$ concentrations.	0
521	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
522	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
523	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
524	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
525	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
526	Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of @PROTEIN$ deletion on sustained behavioral responses elicited by repeated @COMPOUND$ administration.	0
527	Decreased @PROTEIN$ expression increases extracellular @COMPOUND$ and alters its regulation in mouse striatum.	1
528	injection of @PROTEIN$ provoked a significant increase in plasma @COMPOUND$ level.	1
529	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
530	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
531	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
532	Tumor @PROTEIN$ differs from normal MUC1 by modified @COMPOUND$ side chains.	0
533	Mineralization and dehalogenation of @COMPOUND$ was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).	1
534	Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of @COMPOUND$ ions from the halogenated compound (approximately 80%).	0
535	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
536	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
537	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
538	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
539	Metabolism of @COMPOUND$ by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.	1
540	Metabolism of dextrorphan by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of @COMPOUND$ metabolism.	0
541	@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
542	@PROTEIN$ (CYP2D6) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
543	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of @COMPOUND$ (DOR) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
544	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (DOR) from @COMPOUND$ (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
545	@PROTEIN$ (CYP2D6) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
546	Cytochrome P450 2D6 (@PROTEIN$) mediated formation of dextrorphan (@COMPOUND$) from dextromethorphan (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	1
547	The sequential metabolism of @COMPOUND$ during in vitro studies, particularly using recombinant systems (rCYPs) expressing human @PROTEIN$, is assumed to be negligible.	0
548	The extent of metabolism was investigated for a range of DEX and @COMPOUND$ concentrations in microsomal preparations from three different rCYPs expressing human @PROTEIN$ (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	0
549	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of @COMPOUND$ and HYM using ion-trap mass spectrometry.	1
550	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and @COMPOUND$ using ion-trap mass spectrometry.	1
551	The metal-coordinating residues in the active site of @PROTEIN$ include a conserved @COMPOUND$ that clearly distinguishes this protein from previously structurally characterized members of the M20 peptidase family.	1
552	Finally, the active site of @PROTEIN$ harbors an absolutely conserved @COMPOUND$ (Glu172), which is well positioned to act as a general acid-base residue.	1
553	A significant decrease in mean total nitric oxide (NOx), nitrite, and @COMPOUND$ levels was also found after @PROTEIN$ plus dexamethasone administration.	1
554	A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus @COMPOUND$ administration.	0
555	A significant decrease in mean total @COMPOUND$ (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus dexamethasone administration.	1
556	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
557	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
558	Even if partially compensated with u-PA and protein C, increased FVIII and @PROTEIN$ activity, and decreased nitric oxide levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus @COMPOUND$ administered healthy granulocyte donors.	0
559	Even if partially compensated with u-PA and @PROTEIN$, increased FVIII and vWF activity, and decreased @COMPOUND$ levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus dexamethasone administered healthy granulocyte donors.	0
560	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), @COMPOUND$ (vitamin B(1)) and riboflavin (vitamin B(2)).	1
561	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, @COMPOUND$, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
562	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, @COMPOUND$ (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
563	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, @COMPOUND$, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
564	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, @COMPOUND$, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
565	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), @COMPOUND$ (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
566	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (@COMPOUND$), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
567	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, @COMPOUND$, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
568	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of @COMPOUND$, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
569	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), @COMPOUND$ (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
570	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and @COMPOUND$ (vitamin B(2)).	1
571	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
572	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
573	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
574	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
575	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1
576	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1
577	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
578	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
579	Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
580	Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
581	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
582	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
583	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
584	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
585	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
586	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
587	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
588	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
589	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
590	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
591	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
592	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
593	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of @PROTEIN$ and ERbeta expression.	1
594	These effects of @COMPOUND$ during the differentiation period were associated with down-regulation of ERalpha and @PROTEIN$ expression.	1
595	Activities of microbial extracellular enzymes involved in carbon, @COMPOUND$, and phosphorus cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
596	Activities of microbial extracellular enzymes involved in carbon, nitrogen, and @COMPOUND$ cycling declined appreciably with depth, the only exception being @PROTEIN$.	0
597	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
598	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
599	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
600	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0
601	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0
602	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
603	Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of @PROTEIN$-ir axons ; this suggests that the marked expansion of the @COMPOUND$ innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.	0
604	@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1
605	Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1
606	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
607	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
608	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
609	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
610	@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1
611	Long-chain @COMPOUND$ also reduced @PROTEIN$-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.	1
612	@COMPOUND$ is released from human monocyte-derived macrophages upon stimulation with @PROTEIN$ and is a sensitive indicator for cellular immune activation.	1
613	Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1
614	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of @COMPOUND$ (ATP) needed for the maintenance of ion gradients across membranes.	1
615	@PROTEIN$ deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of adenosine triphosphate (@COMPOUND$) needed for the maintenance of ion gradients across membranes.	1
616	This prospective cross-sectional study was performed to investigate the influence of GH excess on @PROTEIN$ and ghrelin levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
617	This prospective cross-sectional study was performed to investigate the influence of GH excess on leptin and @PROTEIN$ levels at baseline and after @COMPOUND$ load in a large group of acromegalic patients.	0
618	@PROTEIN$ digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of @COMPOUND$.	0
619	DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1
620	We found that the third @COMPOUND$ in @PROTEIN$, Cys122, is oxidized to a sulfenic acid.	0
621	We found that the third cysteine in @PROTEIN$, Cys122, is oxidized to a @COMPOUND$.	0
622	E. coli thioredoxin reductase and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced @PROTEIN$.	1
623	E. coli @PROTEIN$ and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced YhaK.	0
624	In experiment 3, administration of E(2) or @COMPOUND$ to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that @PROTEIN$ may be required for some of the anti-depressant-like effects of E(2).	0
625	@COMPOUND$ treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (@PROTEIN$) and AKT was markedly increased in vivo.	1
626	In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1
627	In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1
628	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
629	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
630	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
631	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
632	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
633	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
634	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
635	In this paper we demonstrate that hedgehog signaling antagonists, including @COMPOUND$, and a second compound, CUR0199691, can inhibit growth of @PROTEIN$ (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.	0
636	The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0
637	@COMPOUND$ (NO), which is produced by nitric oxide synthase (@PROTEIN$), may play a role in the development of ASD.	1
638	@COMPOUND$ (NO), which is produced by @PROTEIN$ (NOS), may play a role in the development of ASD.	1
639	Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0
640	@COMPOUND$ upregulates @PROTEIN$ activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.	1
641	It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1
642	Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0
643	@COMPOUND$ release and gene expressions of @PROTEIN$ and MCP-1 in porcine alveolar epithelial type II cells.	0
644	@COMPOUND$ release and gene expressions of IL-8 and @PROTEIN$ in porcine alveolar epithelial type II cells.	0
645	These findings suggest that AEC IIs play an important role in initial inflammatory reactions of the lung by releasing @COMPOUND$, and that they also modulate later inflammatory reactions, evidenced by consistent elevation of @PROTEIN$ gene expression after and during exogenous challenge in pigs.	0
646	Sialic acid-specific O-@PROTEIN$ and O-acetylesterases are responsible for the metabolism of esterified @COMPOUND$.	1
647	Sialic acid-specific O-acetyltransferases and O-@PROTEIN$ are responsible for the metabolism of esterified @COMPOUND$.	1
648	Furthermore, 8-bromo-cGMP and @COMPOUND$ failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
649	Furthermore, @COMPOUND$ and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on @PROTEIN$ rather than through classical NO signaling pathways.	0
650	@COMPOUND$ decreases expression of osmoprotective genes via direct inhibition of @PROTEIN$ transcriptional activity.	1
651	Because @COMPOUND$ (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and @PROTEIN$ activation in MDCK cells.	0
652	@COMPOUND$, acting on P2X (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (@PROTEIN$), and following prolonged agonist exposure, cell death.	1
653	@COMPOUND$, acting on @PROTEIN$ (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (IL-1beta), and following prolonged agonist exposure, cell death.	1
654	While the total @PROTEIN$ released during a 1 h @COMPOUND$ stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in insulin release from hydrogel samples within the 1 h stimulation period.	1
655	Ischaemia and @PROTEIN$, but not ischaemia and contraction, act synergistically in stimulating muscle @COMPOUND$ uptake in vivo in humans.	1
656	In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1
657	7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of CYP1A1 and @PROTEIN$ which are known to be responsive to PAH.	1
658	7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of @PROTEIN$ and CYP1B1 which are known to be responsive to PAH.	1
659	Extracellular lipase @PROTEIN$ prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
660	Extracellular @PROTEIN$ LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
661	The high purity (@COMPOUND$ (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
662	The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
663	The high purity (@COMPOUND$ (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
664	The high purity (S)-ibuprofen (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
665	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
666	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both @PROTEIN$ and BDNF.	1
667	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both NGF and @PROTEIN$.	1
668	@COMPOUND$ induces PON1 expression through p44/42 mitogen-activated @PROTEIN$ signaling cascade in Huh7 cells.	1
669	@COMPOUND$ induces PON1 expression through @PROTEIN$/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
670	@COMPOUND$ induces @PROTEIN$ expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.	1
671	Both @PROTEIN$ gene promoter activity and PON1 protein expression were elevated by @COMPOUND$ stimulation.	1
672	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
673	@COMPOUND$ increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by PD98059.	1
674	Pitavastatin increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by @COMPOUND$.	1
675	Pitavastatin increased the @PROTEIN$-PON1 DNA complex and this effect was attenuated by @COMPOUND$.	1
676	@COMPOUND$ increased the Sp1-@PROTEIN$ DNA complex and this effect was attenuated by PD98059.	1
677	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
678	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
679	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
680	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
681	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
682	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
683	Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0
684	Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1
685	Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
686	Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
687	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (MRS-2179), and P2Y12 (@COMPOUND$) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
688	The interaction between PAF and the platelet agonists ADP, @PROTEIN$ and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (@COMPOUND$), and P2Y12 (cangrelor) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	0
689	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	0
690	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
691	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	1
692	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	1
693	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
694	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	0
695	Improved hepatic @PROTEIN$ signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic @COMPOUND$ output accordingly.	1
696	These data provide evidence that CMEC express @PROTEIN$, which is able to respond to physiological agonists by mobilizing @COMPOUND$+) from intracellular InsP(3)-sensitive stores.	1
697	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
698	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
699	Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
700	Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
701	@PROTEIN$ was increased by @COMPOUND$ in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	1
702	In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0
703	@PROTEIN$ have the unique ability to catalyze oxidative cleavage of C-C bonds and @COMPOUND$ (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	1
704	Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
705	Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
706	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
707	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
708	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, @PROTEIN$ and TSH, seen in both Snell and Ames dwarf mice.	0
709	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce @COMPOUND$ utilization besides elevated adiponectin, reduced @PROTEIN$ and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice.	0
710	Therefore, @COMPOUND$, which inhibit the production of @PROTEIN$ by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	1
711	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
712	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the ZNF230 promoter contained a functional @PROTEIN$ site.	1
713	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the @PROTEIN$ promoter contained a functional Sp1 site.	1
714	@COMPOUND$ effects on neuronal ultrastructure and expression of @PROTEIN$ (MAP2) in rats with acute spinal cord injury.	1
715	@COMPOUND$ effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (@PROTEIN$) in rats with acute spinal cord injury.	1
716	(4) Our data indicated that @COMPOUND$ maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of @PROTEIN$, suggesting a protective effect during the early phases of spinal cord injury.	1
717	In conclusion, our results indicate that chronic @COMPOUND$ modulates the expression and subcellular localization of proteins implicated in @PROTEIN$ signaling, calcium-buffering potential, and trafficking.	1
718	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0
719	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0
720	High @COMPOUND$ and @PROTEIN$ synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.	0
721	High @COMPOUND$ and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor @PROTEIN$ activity.	1
722	High @COMPOUND$ and interferon gamma synergistically stimulate @PROTEIN$ expression in U937 macrophages by increasing transcription factor STAT1 activity.	1
723	To test our hypothesis that hyperglycemia interplays with @PROTEIN$ (IFN gamma), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
724	To test our hypothesis that hyperglycemia interplays with interferon gamma (@PROTEIN$), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
725	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, MMP-9 and @PROTEIN$.	1
726	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of @PROTEIN$, MMP-9 and IL-1 beta.	1
727	Results showed that high @COMPOUND$ and @PROTEIN$ had a synergistic effect on the expression of MMP-1, MMP-9 and IL-1 beta.	0
728	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, @PROTEIN$ and IL-1 beta.	1
729	Furthermore, high @COMPOUND$ and IFN gamma exert the synergistic effect on MMP-1 expression by enhancing @PROTEIN$ phosphorylation and STAT1 transcriptional activity.	1
730	Furthermore, high @COMPOUND$ and @PROTEIN$ exert the synergistic effect on MMP-1 expression by enhancing STAT1 phosphorylation and STAT1 transcriptional activity.	0
731	Furthermore, high @COMPOUND$ and IFN gamma exert the synergistic effect on @PROTEIN$ expression by enhancing STAT1 phosphorylation and STAT1 transcriptional activity.	1
732	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
733	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
734	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
735	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
736	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
737	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
738	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
739	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
740	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
741	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
742	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
743	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
744	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
745	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
746	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1
747	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1
748	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1
749	The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood @COMPOUND$ (TC) and serum low density lipoprotein (LDL) level, and increase the @PROTEIN$ (HDL) level of the hyperlipemia mice.	0
750	On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0
751	@COMPOUND$ regulates expressions of VEGF and @PROTEIN$ stimulated by STZ.	1
752	@COMPOUND$ regulates expressions of @PROTEIN$ and HIF-1alpha stimulated by STZ.	1
753	In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1
754	NOPE-@COMPOUND$ treatment improved @PROTEIN$ 0.0001).	1
755	The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1
756	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive cortisone to active @COMPOUND$.	1
757	11beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) enzyme catalyzes interconversion of inactive @COMPOUND$ to active cortisol.	1
758	Natural @COMPOUND$ was enzymatically polymerized using soybean @PROTEIN$.	1
759	These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0
760	Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1
761	In combination with an @PROTEIN$ mutation generated and introduced into the chromosome, an accumulation of up to 54 mM @COMPOUND$ was achieved as compared to 21 mM obtained with the ancestor strain.	1
762	This additive effect was not observed when glioma cells were pre-treated with @COMPOUND$, which was unable to increase @PROTEIN$ expression in tumor.	0
763	Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1
764	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
765	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
766	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
767	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
768	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
769	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
770	@COMPOUND$ can support the formation of membranous structures and an increase in @PROTEIN$ mRNA levels in differentiating oligodendrocytes.	1
771	@PROTEIN$ elevates @COMPOUND$ levels in the hemolymph by stimulating glycogenolysis in target tissues.	1
772	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0
773	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0
774	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
775	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
776	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
777	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
778	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
779	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
780	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
781	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
782	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
783	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
784	@PROTEIN$ treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to @COMPOUND$.	1
785	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
786	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0
787	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0
788	@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1
789	Our study demonstrates that @COMPOUND$ causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to @PROTEIN$.	1
790	ATP-gated @PROTEIN$ receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous @COMPOUND$ release.	1
791	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released @COMPOUND$ acting on presynaptic @PROTEIN$ receptors.	1
792	Unexpectedly, the data suggest @PROTEIN$ receptor activation initiates a form of asynchronous @COMPOUND$ release, rather than detectably affecting the vesicles underlying action potential evoked release.	1
793	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1
794	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1
795	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is @PROTEIN$-dependent and is associated with enhanced insulin secretion.	1
796	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced @PROTEIN$ secretion.	1
797	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of @PROTEIN$ is JAK2-dependent and is associated with enhanced insulin secretion.	1
798	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1
799	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0
800	In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1
801	@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1
802	The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
803	The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
804	Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
805	Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
806	@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
807	@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
808	A combination of @COMPOUND$ and chromium chloride did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
809	A combination of niacin and @COMPOUND$ did not significantly increase (3+1 mM) but instead reduced (1+3 mM) @PROTEIN$ gene expression.	1
810	We hypothesize that the stimulation of @PROTEIN$ gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by PPARalpha pathway(s).	1
811	We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by @PROTEIN$ pathway(s).	1
812	@COMPOUND$ inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased @PROTEIN$ protein expression at concentrations between 2.5 and 30 muM.	1
813	30 muM, the SUL-induced suppression of @PROTEIN$ protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.	1
814	30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit @PROTEIN$.	0
815	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1
816	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0
817	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0
818	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1
819	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0
820	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1
821	A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0
822	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0
823	@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1
824	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0
825	The structure-activity relationship between @COMPOUND$ derivatives showing inhibitory effects on @PROTEIN$ in mouse macrophage RAW264.7 cells.	1
826	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by lipopolysaccharide.	0
827	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by @COMPOUND$.	1
828	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by @COMPOUND$.	1
829	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by lipopolysaccharide.	0
830	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
831	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
832	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
833	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
834	For this purpose, human erythrocyte @PROTEIN$ was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP @COMPOUND$ 4B affinity gel and Sephadex G-200 gel filtration chromatography.	0
835	The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
836	The enzyme @PROTEIN$ (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
837	In the present study we perform a kinetic analysis of Campylobacter @PROTEIN$ using the continuous spectrophotometric method and show that the enzyme is highly specific for @COMPOUND$ nucleotides.	1
838	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan pyruvate, @COMPOUND$ and indole.	1
839	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from @COMPOUND$ pyruvate, ammonia and indole.	1
840	@PROTEIN$ (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from L-tryptophan @COMPOUND$, ammonia and indole.	1
841	@PROTEIN$ allows soil microorganisms to use @COMPOUND$ as a source of nitrogen and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	1
842	@PROTEIN$ allows soil microorganisms to use urea as a source of @COMPOUND$ and aid in the rapid break down of urea-based fertilizers resulting in phytopathicity.	0
843	@PROTEIN$ is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to @COMPOUND$ imbalance.	0
844	Indoleamine 2,3-dioxygenase (@PROTEIN$) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
845	@PROTEIN$ (IDO) catalyzes the first and rate-limiting step of @COMPOUND$ pathway along the major route of Tryptophan catabolism.	1
846	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
847	@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1
848	Like PSC, DSL6A cells secrete less @PROTEIN$ when cultured with @COMPOUND$.	1
849	Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0
850	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
851	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
852	We measured the ability to increase GABA in eight healthy subjects by comparing the binding of ((11)C) @COMPOUND$, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (@PROTEIN$).	0
853	@PROTEIN$ blockade resulted in significant increases in mean (+/-SD) ((11)C) @COMPOUND$-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	1
854	@PROTEIN$ inhibitory activity of @COMPOUND$ and synergistic effect with acarbose.	1
855	@PROTEIN$ inhibitory activity of cyanidin-3-galactoside and synergistic effect with @COMPOUND$.	1
856	Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0
857	@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0
858	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
859	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
860	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
861	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
862	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
863	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
864	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
865	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
866	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
867	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
868	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
869	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
870	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
871	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
872	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
873	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
874	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
875	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
876	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
877	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
878	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
879	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
880	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (@PROTEIN$), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
881	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), @COMPOUND$ (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
882	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
883	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
884	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
885	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (@PROTEIN$) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
886	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
887	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme @PROTEIN$ (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
888	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
889	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and @COMPOUND$ (DEM)), activities of major detoxification enzymes (general @PROTEIN$ (ESTs), glutathione S-transferases (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
890	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and @COMPOUND$), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
891	The susceptibilities to three organophosphate (OP) insecticides (@COMPOUND$, chlorpyrifos, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
892	The susceptibilities to three organophosphate (OP) insecticides (malathion, @COMPOUND$, and phoxim), responses to three metabolic synergists (triphenyl phosphate (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), @PROTEIN$ (GSTs), and cytochrome P450 monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
893	The susceptibilities to three organophosphate (OP) insecticides (malathion, chlorpyrifos, and phoxim), responses to three metabolic synergists (@COMPOUND$ (TPP), piperonyl butoxide (PBO), and diethyl maleate (DEM)), activities of major detoxification enzymes (general esterases (ESTs), glutathione S-transferases (GSTs), and @PROTEIN$ monooxygenases (P450s)), and sensitivity of the target enzyme acetylcholinesterase (AChE) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	0
894	All these results clearly indicated that the observed @COMPOUND$ resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and @PROTEIN$, and increased activity and reduced sensitivity of AChE to OP inhibition.	1
895	All these results clearly indicated that the observed @COMPOUND$ resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and GSTs, and increased activity and reduced sensitivity of @PROTEIN$ to OP inhibition.	1
896	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between @COMPOUND$ and N-acetylmuramic acid in the peptidoglycan of prokaryotic cell walls.	1
897	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and @COMPOUND$ in the peptidoglycan of prokaryotic cell walls.	1
898	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and N-acetylmuramic acid in the @COMPOUND$ of prokaryotic cell walls.	1
899	We investigated whether several different inflammatory markers including C-reactive protein (@PROTEIN$) and fibrinogen and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
900	We investigated whether several different inflammatory markers including C-reactive protein (CRP) and @PROTEIN$ and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
901	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
902	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
903	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
904	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
905	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
906	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
907	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1
908	In contrast to the behavior in aqueous solution, lactose binding in @COMPOUND$ resulted in an increase of the @PROTEIN$'s radius of gyration from 49+/-1 to 55.5+/-1 A.	1
909	@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
910	Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
911	Our study indicates that brain @PROTEIN$ activity decreases after @COMPOUND$ administration at doses of 30 mg/kg and 100 mg/kg.	1
912	Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-phenyl-beta-D-galactoside and the @COMPOUND$ product resulting from its hydrolysis catalyzed by @PROTEIN$.	1
913	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
914	The planar angle between the carbamoyl phosphate and @COMPOUND$ domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
915	The planar angle between the @COMPOUND$ and aspartate domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
916	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
917	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
918	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
919	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
920	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
921	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
922	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
923	The free radicals produced are thought to be generated during the production of @COMPOUND$, a reaction catalyzed by @PROTEIN$.	1
924	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and @PROTEIN$ activities were observed.	0
925	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and @PROTEIN$ activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
926	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, @PROTEIN$ and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
927	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
928	@PROTEIN$ kinases can be activated by trans-phosphorylation of a @COMPOUND$ located in the central activation loop of the catalytic domain.	1
929	However, because the required exposure of this @COMPOUND$ is not observed in the down-regulated X-ray structures of @PROTEIN$ kinases, transient partial opening of the activation loop appears to be necessary for such processes.	0
930	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing @COMPOUND$ or trehalose across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
931	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing sucrose or @COMPOUND$ across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
932	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
933	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
934	@COMPOUND$ increased the levels of CD95 (@PROTEIN$), CD95-ligand and Fas-associated death domain.	1
935	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
936	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
937	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
938	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
939	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
940	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
941	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
942	Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
943	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
944	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0
945	In addition to transporting @COMPOUND$, @PROTEIN$ plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
946	In addition to transporting glutamate, @PROTEIN$ plays other roles in regulating @COMPOUND$ synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
947	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
948	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
949	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
950	Here we report a case of intragenic @PROTEIN$ microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by @COMPOUND$.	1
951	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and insulin secretion.	1
952	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate @COMPOUND$-induced changes in ATP/ADP ratio and @PROTEIN$ secretion.	1
953	@PROTEIN$ is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and insulin secretion.	1
954	UCP2 is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate glucose-induced changes in @COMPOUND$/ADP ratio and @PROTEIN$ secretion.	0
955	Neither @PROTEIN$ expression nor UCP2 overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
956	Neither UCP1 expression nor @PROTEIN$ overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
957	The @PROTEIN$ activity was increased by Mn(2+), @COMPOUND$+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
958	The @PROTEIN$ activity was increased by @COMPOUND$+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
959	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and @COMPOUND$+).	1
960	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by @COMPOUND$+) and Ba(2+).	1
961	Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and @COMPOUND$ were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
962	Meanwhile, SDS, ethyleneglycoltetraacetic acid, @COMPOUND$, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
963	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
964	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
965	These results are in contrast to postmortem findings in schizophrenia and suggest that reduced @PROTEIN$ protein levels in schizophrenia patients' postmortem brain do not result from perinatal @COMPOUND$ deprivation.	0
966	We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
967	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
968	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0
969	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
970	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
971	However, OPN-(/-) mice showed increased serum levels of tumour necrosis factor (@PROTEIN$)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
972	However, @PROTEIN$-(/-) mice showed increased serum levels of tumour necrosis factor (TNF)-alpha, which could be due to systemically present @COMPOUND$ translocated to the gut.	1
973	The expression of the ERG1, ERG3, ERG7, @PROTEIN$, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
974	The expression of the ERG1, ERG3, ERG7, ERG9, @PROTEIN$ and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
975	The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and @PROTEIN$ genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
976	The expression of the ERG1, @PROTEIN$, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
977	The expression of the @PROTEIN$, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
978	The expression of the ERG1, ERG3, @PROTEIN$, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
979	Expression of the @PROTEIN$ gene was found to be low or moderate and it was regulated by @COMPOUND$ addition more so than by biofilm formation.	1
980	The expression of the @PROTEIN$ increased in the presence of @COMPOUND$ in some isolates.	1
981	Concentrations of @COMPOUND$ 1000 and Na2SO4 were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
982	Concentrations of polyethylene glycol 1000 and @COMPOUND$ were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of @PROTEIN$, purification factor and pectinase yield.	0
983	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
984	In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
985	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
986	@COMPOUND$, an inhibitor of glial metabolism, inhibits the up-regulation of @PROTEIN$ expression, activity and NO production in the spinal cord induced by formalin test in rats.	1
987	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of @COMPOUND$ (FC), an inhibitor of glial metabolism, on @PROTEIN$ expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	0
988	Oral administration of @COMPOUND$ remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total bilirubin levels.	1
989	Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total @COMPOUND$ levels.	0
990	Here we show that @PROTEIN$ selectively increases the power of @COMPOUND$-induced, but not carbachol-induced, gamma oscillations in acute hippocampal slices.	1
991	Here we show that @PROTEIN$ selectively increases the power of kainate-induced, but not @COMPOUND$-induced, gamma oscillations in acute hippocampal slices.	0
992	These effects of @PROTEIN$beta are blocked by @COMPOUND$, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.	1
993	We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0
994	We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1
995	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
996	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
997	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of O-GlcNAc correlating changes in @PROTEIN$ expression, but not in @COMPOUND$ pools.	0
998	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of @PROTEIN$ correlating changes in OGT expression, but not in @COMPOUND$ pools.	0
999	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before @PROTEIN$ and Mos-Erk2 pathways activations.	1
1000	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and @PROTEIN$-Erk2 pathways activations.	1
1001	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and Mos-@PROTEIN$ pathways activations.	1
1002	Upon @COMPOUND$ stimulation, an @PROTEIN$ level burst occurred during meiotic resumption long before MPF and Mos-Erk2 pathways activations.	1
1003	Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
1004	Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
1005	Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1006	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1007	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
1008	Affinity assays were performed to measure endogenous @COMPOUND$-bound @PROTEIN$, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.	1
1009	Affinity assays were performed to measure endogenous @COMPOUND$-bound Rho, and confocal microscopy was used to assess changes in organization of the @PROTEIN$ cytoskeleton.	0
1010	IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1011	@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
1012	Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0
1013	Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1
1014	Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0
1015	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1016	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1017	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1018	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1019	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1020	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1021	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1022	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1023	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
1024	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
1025	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1026	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by @COMPOUND$ (OAG) and other amphipaths.	1
1027	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by @COMPOUND$ (OAG) and other amphipaths.	1
1028	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
1029	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
1030	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
1031	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of @PROTEIN$ and PARP, and inhibition of bcl-2.	0
1032	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of @PROTEIN$.	0
1033	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and @PROTEIN$, and inhibition of bcl-2.	0
1034	Dopamine release and direct stimulation of dopamine D2 and serotonin @PROTEIN$ receptors also contributes to the overall action of @COMPOUND$.	1
1035	Our findings suggest that @COMPOUND$ differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the @PROTEIN$ receptor system.	0
1036	These results suggest that @PROTEIN$ does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive @COMPOUND$ treatment.	0
1037	@COMPOUND$ is a chemical carcinogen found in tobacco smoke that causes activating mutations in @PROTEIN$ and induces lung tumors in mice.	1
1038	In the present study, we measured plasma @PROTEIN$ levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli @COMPOUND$ per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	0
1039	Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1
1040	Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0
1041	Heparin (H), @COMPOUND$ (A), anti@PROTEIN$ III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1042	Heparin (H), @COMPOUND$ (A), antithrombin III (ATIII), and recombinant human activated @PROTEIN$ (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1043	Heparin (H), @COMPOUND$ (A), antithrombin III (@PROTEIN$), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1044	Heparin (H), @COMPOUND$ (A), @PROTEIN$ (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
1045	According to @PROTEIN$-binding, arsenic trioxide (7 microM) within 48 h significantly increased @COMPOUND$ exposure of human erythrocytes without inducing hemolysis.	0
1046	Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with @COMPOUND$ blunted the effects of arsenic on @PROTEIN$-binding and cell shrinkage.	1
1047	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1048	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1049	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1050	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), @COMPOUND$ (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1051	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1052	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1053	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and xanthoxyletin (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles @COMPOUND$ (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1054	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), osthol (4), and @COMPOUND$ (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles heptaphylline (1) and 7-methoxyheptaphylline (2) on inducible-@PROTEIN$ (iNOS) expression induced by lipopolysaccharide (LPS) and the NO generation in RAW 264.7 mouse macrophages.	0
1055	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
1056	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
1057	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low @COMPOUND$ (rT3) levels.	1
1058	Mutations in @PROTEIN$ are associated with severe psychomotor retardation, high serum T3 and low 3,3',5'-triiodothyronine (@COMPOUND$) levels.	1
1059	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and @PROTEIN$ (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
1060	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, @PROTEIN$, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
1061	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and @PROTEIN$) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
1062	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, @PROTEIN$-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
1063	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (@PROTEIN$, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
1064	In utero exposure to @COMPOUND$ reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of @PROTEIN$ and AR of foetal male rat testis.	1
1065	mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1
1066	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1067	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
1068	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
1069	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
1070	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
1071	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
1072	Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1
1073	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1074	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
1075	Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0
1076	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1077	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
1078	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
1079	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
1080	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
1081	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
1082	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (@PROTEIN$ (2)) release and cyclooxygenase-2 (COX-2) expression in bovine synovial fibroblasts (SFs).	0
1083	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and cyclooxygenase-2 (@PROTEIN$) expression in bovine synovial fibroblasts (SFs).	0
1084	To investigate the role of @COMPOUND$ analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (PGE (2)) release and @PROTEIN$ (COX-2) expression in bovine synovial fibroblasts (SFs).	0
1085	In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1086	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1087	In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1088	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
1089	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1
1090	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1
1091	@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1
1092	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
1093	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
1094	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
1095	Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
1096	@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
1097	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
1098	To elucidate the mechanism by which @COMPOUND$ regulates adipose triglyceride @PROTEIN$ (ATGL).	1
1099	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1100	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1101	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
1102	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
1103	@COMPOUND$ was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer @PROTEIN$-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.	1
1104	In our earlier method, glutathione disulfide (@COMPOUND$) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
1105	In our earlier method, @COMPOUND$ (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
1106	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of @COMPOUND$.	1
1107	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to @COMPOUND$ with @PROTEIN$ (GR) in the presence of NADPH.	1
1108	The @PROTEIN$ insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent @COMPOUND$ generation: potential implication in hypertension.	1
1109	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1
1110	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1
1111	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1
1112	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma @COMPOUND$-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1113	The results showed that the intakes of dry matter (DM), organic matter (OM), @COMPOUND$ (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1114	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary @COMPOUND$ derivatives (PD) excretion, the ratios of allantoin to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1115	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to creatinine (@COMPOUND$), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1116	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of allantoin to @COMPOUND$ (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1117	The results showed that the intakes of dry matter (DM), organic matter (OM), nitrogen (N), the N-balance, urinary purine derivatives (PD) excretion, the ratios of @COMPOUND$ to creatinine (CR), PD to CR, the plasma urea-N (PUN) and @PROTEIN$ increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	0
1118	Activation of interleukin-6/@PROTEIN$ in rat cholangiocyte proliferation induced by @COMPOUND$.	1
1119	Activation of @PROTEIN$/STAT3 in rat cholangiocyte proliferation induced by @COMPOUND$.	1
1120	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
1121	Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on @COMPOUND$ with surface-grafted chitosan and immobilized bone @PROTEIN$-2.	0
1122	Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1
1123	Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1
1124	@COMPOUND$ (RA) treatment increased this @PROTEIN$ promoter-luciferase activity in PrEC cells, but not in PC-3 cells.	1
1125	@COMPOUND$ (RA) treatment increased this LRAT promoter-@PROTEIN$ activity in PrEC cells, but not in PC-3 cells.	1
1126	Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
1127	Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
1128	The @COMPOUND$ functionalization was then used to immobilize bone @PROTEIN$ on the bioactive glasses.	1
1129	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1130	L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1131	L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1132	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
1133	L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0
1134	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1
1135	Exposure to @COMPOUND$ (BaP) by intraperitoneal injection increased biliary BaP metabolites and liver @PROTEIN$ gene expression.	1
1136	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1137	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1138	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1139	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1140	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1141	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1142	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1143	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1144	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1145	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1146	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1147	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1148	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1149	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1150	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1151	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1152	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1153	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1154	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
1155	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
1156	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and SOD, @PROTEIN$ and GPx activities, were determined.	1
1157	Erythrocytes were incubated under various treatment conditions (@COMPOUND$ alone, vitamins alone, or malathion plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and @PROTEIN$, CAT and GPx activities, were determined.	0
1158	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
1159	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
1160	@PROTEIN$ reduces antioxidant defense system and enhances kidney tissue damage in @COMPOUND$ and lead exposed rats.	1
1161	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1162	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1163	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1164	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1165	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1166	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1167	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1168	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
1169	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1170	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
1171	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
1172	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
1173	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
1174	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
1175	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
1176	Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1
1177	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
1178	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
1179	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1
1180	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
1181	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
1182	Therefore, we next examined whether @PROTEIN$ and 5-HT2C receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0
1183	Therefore, we next examined whether @COMPOUND$2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the formalin test.	0
1184	Therefore, we next examined whether 5-HT2A and @PROTEIN$ receptors are involved, and from where 5-HT is released in the @COMPOUND$ test.	0
1185	These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, @PROTEIN$ as well as 5-HT2C, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1
1186	These results indicate that @COMPOUND$ released into peripheral tissue and its receptors, 5-HT2A as well as @PROTEIN$, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	1
1187	@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1
1188	In contrast, the administration of @COMPOUND$ significantly attenuated the immobilization stress-induced decrease in @PROTEIN$ 0.01).	1
1189	@COMPOUND$ exhibited differential effects on @PROTEIN$ mRNA expression in the rat hippocampus and neocortex.	1
1190	These results suggest that @COMPOUND$ might have a neuroprotective effect by recovering stress-induced decreases in @PROTEIN$ mRNA expression.	1
1191	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated hemoglobin (HbA1c) and serum @PROTEIN$ were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
1192	Clinical and biochemical parameters including @COMPOUND$ (FAM), glycated @PROTEIN$ (HbA1c) and serum AGEs were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	0
1193	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1194	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
1195	Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
1196	@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
1197	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
1198	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
1199	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/@PROTEIN$ and fli1.	0
1200	These vessels are formed by proliferating cells that incorporate @COMPOUND$ and express the endothelial cell markers vegfr2/kdr and @PROTEIN$.	0
1201	Moreover, similar to rFGF2, injection of the zebrafish form of @PROTEIN$ (VEGF-A) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
1202	Moreover, similar to rFGF2, injection of the zebrafish form of vascular endothelial growth factor-A (@PROTEIN$) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
1203	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/@PROTEIN$ (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1204	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and @PROTEIN$ (MAPKs) by reducing oxidative stress in aged rats.	1
1205	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (NIK)/IkappaB kinase (IKK) and mitogen-activated protein kinases (@PROTEIN$) by reducing oxidative stress in aged rats.	1
1206	In this study, we examined @COMPOUND$ for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (@PROTEIN$)/IkappaB kinase (IKK) and mitogen-activated protein kinases (MAPKs) by reducing oxidative stress in aged rats.	1
1207	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory @PROTEIN$, iNOS, VCAM-1 and ICAM-1.	1
1208	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, @PROTEIN$ and ICAM-1.	1
1209	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, @PROTEIN$, VCAM-1 and ICAM-1.	1
1210	Data show that in aged kidney tissue, @COMPOUND$ exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory COX-2, iNOS, VCAM-1 and @PROTEIN$.	1
1211	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of @PROTEIN$/IKK and MAPKs.	1
1212	The molecular modulation of NF-kappaB by @COMPOUND$ was further revealed in endothelial YPEN-1 cells through ferulate's ability to suppress the activation of NIK/IKK and @PROTEIN$.	1
1213	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of @PROTEIN$/IKK and MAPKs in vivo.	1
1214	Based on these results, we conclude that @COMPOUND$'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of NIK/IKK and @PROTEIN$ in vivo.	1
1215	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1216	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
1217	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1218	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1219	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1220	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1221	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
1222	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
1223	GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of @COMPOUND$, and less than 10% expressed the proliferative markers Ki67 and @PROTEIN$.	0
1224	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
1225	The discovery that a common polymorphism (@COMPOUND$TLPR, short variant) in the human serotonin transporter gene (@PROTEIN$) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (5-HT) during development could be critical for the establishment of brain circuits.	0
1226	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
1227	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
1228	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
1229	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
1230	Prior to the first dose of @COMPOUND$, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and @PROTEIN$ level with DAS.	0
1231	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
1232	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, @PROTEIN$, ERG11, ERG24, ERG25 and ERG26.	1
1233	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, @PROTEIN$, ERG24, ERG25 and ERG26.	1
1234	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including @PROTEIN$, ERG7, ERG11, ERG24, ERG25 and ERG26.	1
1235	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, @PROTEIN$ and ERG26.	1
1236	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, ERG24, ERG25 and @PROTEIN$.	1
1237	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to @COMPOUND$, including ERG6, ERG7, ERG11, @PROTEIN$, ERG25 and ERG26.	1
1238	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
1239	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1240	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1241	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1242	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1243	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1244	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
1245	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1246	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
1247	@COMPOUND$ attenuated mast cell recruitment thereby decreased the expressions of @PROTEIN$ and 9 in rat liver carcinogenesis.	1
1248	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of MMP-2 and @PROTEIN$.	1
1249	@COMPOUND$ administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of @PROTEIN$ and MMP-9.	1
1250	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of @PROTEIN$ and MMP-9 as revealed by Western blotting and immunohistochemistry.	1
1251	@COMPOUND$ treatment inhibited this increase in MCD and downregulated the expressions of MMP-2 and @PROTEIN$ as revealed by Western blotting and immunohistochemistry.	1
1252	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of @PROTEIN$ and MMP-9.	1
1253	In conclusion, @COMPOUND$ exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of MMP-2 and @PROTEIN$.	1
1254	As a result, combined @COMPOUND$ and @PROTEIN$ infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	0
1255	@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1
1256	@PROTEIN$ was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the @COMPOUND$/PKA pathway.	1
1257	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
1258	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
1259	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1260	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
1261	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
1262	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in @PROTEIN$-mediated VEGF biosynthesis in keratinocytes.	0
1263	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated @PROTEIN$ biosynthesis in keratinocytes.	0
1264	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of @PROTEIN$ protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes.	0
1265	Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1
1266	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (PKCalpha, @PROTEIN$, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
1267	It was observed that administration of the PKC inhibitor @COMPOUND$ (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (@PROTEIN$, PKCdelta, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	1
1268	@COMPOUND$ is known to have regulatory effects on gastrointestinal functions via the vanilloid receptor (@PROTEIN$).	1
1269	DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1270	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1271	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1272	DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
1273	Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1
1274	@COMPOUND$ exposures that caused a loss of binding function were examined for effects on expression of key NK cell-@PROTEIN$ needed for binding to targets.	0
1275	Here, we have investigated how the post-synthetic acetylation of @PROTEIN$ affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from @COMPOUND$-treated cells.	0
1276	@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1
1277	@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1
1278	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1279	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1280	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1281	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1282	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1283	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
1284	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
1285	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
1286	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
1287	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
1288	Western blotting showed that @COMPOUND$ down-regulated @PROTEIN$ protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	1
1289	In addition, AIT induced a more favourable regulation of blood @COMPOUND$ and @PROTEIN$ compared with MTG.	0
1290	Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1291	Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1292	Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
1293	When compared to the other mammalian @PROTEIN$ genes, the porcine coding sequence contained a single @COMPOUND$ codon inserted into the region encoding the cytoplasmic domain.	1
1294	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins @PROTEIN$ and Bcl-xl, but promoted the levels of the pro-apoptotic protein Bax.	1
1295	@COMPOUND$ inhibited the levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl, but promoted the levels of the pro-apoptotic @PROTEIN$.	1
1296	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1297	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1298	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1299	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
1300	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of @PROTEIN$ and Bax, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
1301	In conclusion, Gyp induced ER stress and production of reactive oxygen species and @COMPOUND$+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	0
1302	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and Bax, followed by the dysfunction of mitochondria, caused @PROTEIN$ release, activation of caspase-3 before leading to apoptosis.	1
1303	In conclusion, Gyp induced ER stress and production of reactive @COMPOUND$ species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	0
1304	In conclusion, @COMPOUND$ induced ER stress and production of reactive oxygen species and Ca(2+), change the ratio of Bcl-2 and @PROTEIN$, followed by the dysfunction of mitochondria, caused cytochrome c release, activation of caspase-3 before leading to apoptosis.	1
1305	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1306	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1307	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
1308	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1309	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1310	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1311	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1312	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
1313	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
1314	Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	0
1315	Exposure of erythrocytes to @PROTEIN$ increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	1
1316	Exposure of erythrocytes to PGNs increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	0
1317	Exposure of erythrocytes to @PROTEIN$ increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	1
1318	Elevated beta1,4-@PROTEIN$-I induced by the intraspinal injection of @COMPOUND$.	1
1319	E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0
1320	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-@COMPOUND$, (3)H-lysine, and (3)H-methylaminoisobutyric acid, respectively.	0
1321	Effects of @PROTEIN$ on amino acid transporters were examined using their substrates: (3)H-phenylalanine, (3)H-@COMPOUND$, and (3)H-methylaminoisobutyric acid, respectively.	0
1322	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
1323	In this study, we investigated the molecular mechanism through which @PROTEIN$ is up-regulated by @COMPOUND$ using cultured human neuron-like cells.	1
1324	@COMPOUND$, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both @PROTEIN$ messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	1
1325	@COMPOUND$ increased transcriptional activity of a human @PROTEIN$ promoter-reporter gene construct.	1
1326	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and @COMPOUND$-induced promoter activities and lowered @PROTEIN$ protein levels.	0
1327	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1328	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
1329	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1330	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
1331	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
1332	With covalent method, @COMPOUND$ was introduced to immobilize @PROTEIN$.	1
1333	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
1334	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
1335	Activities of antioxidant enzymes (@PROTEIN$, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1336	Activities of antioxidant enzymes (superoxide dismutase, catalase, @PROTEIN$, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1337	Activities of antioxidant enzymes (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1338	Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
1339	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1340	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0
1341	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
1342	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0
1343	Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0
1344	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0
1345	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1
1346	Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1
1347	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0
1348	We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1
1349	We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0
1350	Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1
1351	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1
1352	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1
1353	Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0
1354	@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1
1355	Overall, these findings indicate that, in addition to modulating @PROTEIN$ protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.	1
1356	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein @PROTEIN$.	1
1357	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the @PROTEIN$ HuR.	0
1358	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (@PROTEIN$), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1359	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; @PROTEIN$/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1360	Immunoblot analysis of signaling molecules, including cyclic-AMP response element binding protein (CREB), @PROTEIN$ (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	1
1361	Immunoblot analysis of signaling molecules, including cyclic-@PROTEIN$ response element binding protein (CREB), mitogen-activated protein kinases (MAPKp44/42; ERK1/2), in area CA1 revealed that @COMPOUND$ treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	0
1362	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
1363	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
1364	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
1365	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
1366	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
1367	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
1368	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	0
1369	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1370	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1371	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1372	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1373	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	0
1374	The adsorption of ovine @PROTEIN$ onto @COMPOUND$-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.	1
1375	When the @PROTEIN$ concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed @COMPOUND$ microspheres.	1
1376	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1377	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1378	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1
1379	The combined treatment strategy not only decreased @PROTEIN$-positive aggregation in striatum, alleviated @COMPOUND$ aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.	0
1380	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
1381	Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0
1382	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
1383	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
1384	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
1385	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
1386	The @PROTEIN$ amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of @COMPOUND$ with a little increase in the amount of vanillin production.	1
1387	The real synergistic effect of @PROTEIN$ amplification and icdA deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1
1388	The real synergistic effect of gltA amplification and @PROTEIN$ deletion was observed with use of XAD-2 resin reducing the toxicity of @COMPOUND$ produced during culture.	1
1389	A 3-fold increase in the expression of the @PROTEIN$ gene was associated with decreased @COMPOUND$ methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.	0
1390	ALK2 (R206H) with @PROTEIN$ or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1391	ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by @PROTEIN$ or @COMPOUND$.	0
1392	ALK2 (R206H) with Smad1 or @PROTEIN$ induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1393	@PROTEIN$ (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1394	Combustion products of @COMPOUND$ inhibit @PROTEIN$ activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.	0
1395	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1
1396	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0
1397	In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1
1398	In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0
1399	Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0
1400	Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0
1401	Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1
1402	@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1
1403	Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1
1404	In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1
1405	In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1
1406	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
1407	The @PROTEIN$-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	0
1408	The IL-13-induced up-regulation of @PROTEIN$ was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (STAT6).	1
1409	The IL-13-induced up-regulation of RhoA was inhibited by @COMPOUND$, an inhibitor of signal transducer and activator of transcription 6 (@PROTEIN$).	1
1410	The goal of this study was to determine the mechanisms by which @COMPOUND$ induces @PROTEIN$ gene expression in airway epithelial cells.	1
1411	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced @PROTEIN$/2-MAPK activation and MUC5B gene expression.	1
1412	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-@PROTEIN$ activation and MUC5B gene expression.	1
1413	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-MAPK activation and @PROTEIN$ gene expression.	1
1414	We here show that calumenin in the presence of @COMPOUND$+) binds to @PROTEIN$ with a dissociation constant K (d) around 0.4 muM.	1
1415	We examined whether @COMPOUND$ produced locally in the brain may contribute to the activation of @PROTEIN$ in the CNS.	1
1416	However, as opposed to exogenous @COMPOUND$, the continuous use of @PROTEIN$ during in vitro differentiation completely blocked rMSC mineralization.	0
1417	We show that the effects of both @PROTEIN$-2 and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
1418	We show that the effects of both @PROTEIN$ and @COMPOUND$ are mediated through FGF receptor 1 (FGFR1) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	0
1419	We show that the effects of both FGF-2 and @COMPOUND$ are mediated through FGF receptor 1 (@PROTEIN$) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	1
1420	Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0
1421	Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1422	Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1423	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1424	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1425	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1426	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1427	@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1
1428	The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0
1429	The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0
1430	Treatment of mouse macrophages with d-/l-@COMPOUND$ (50microM) induced depletion of intracellular glutathione and a compensatory increase in @PROTEIN$ activity.	1
1431	Treatment of mouse macrophages with d-/l-homocysteine (50microM) induced depletion of intracellular @COMPOUND$ and a compensatory increase in @PROTEIN$ activity.	0
1432	Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with @COMPOUND$, and this occurred via increased transcription as demonstrated with @PROTEIN$ promoter reporter constructs for Gclc.	0
1433	Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1434	Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0
1435	Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
1436	@COMPOUND$ and @PROTEIN$ up-regulated cyclinD1 (CD1) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	0
1437	@COMPOUND$ and EGF up-regulated cyclinD1 (@PROTEIN$) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only CD1 protein expression.	1
1438	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in @PROTEIN$ secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.	1
1439	High @COMPOUND$ induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of @PROTEIN$ prenylation via suppression of the mevalonate pathway.	1
1440	The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0
1441	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1442	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1443	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1444	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1445	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1446	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1447	Accumulation of @COMPOUND$ in PA was increased by @PROTEIN$ at 10nM and by IGF-I at 1 nM and 10nM.	1
1448	Accumulation of @COMPOUND$ in PA was increased by insulin at 10nM and by @PROTEIN$ at 1 nM and 10nM.	1
1449	It was shown that PAR significantly increased serum ALT, @PROTEIN$, ALP, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1450	It was shown that PAR significantly increased serum ALT, AST, @PROTEIN$, liver MDA levels and significantly decreased liver @COMPOUND$-Px activity, when compared to the control group (Group 1).	0
1451	The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1
1452	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1453	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1454	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1455	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1456	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1457	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1458	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
1459	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
1460	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
1461	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1462	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1463	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
1464	Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1
1465	During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1
1466	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1467	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1468	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1469	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1470	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
1471	In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1
1472	These data establish that in the vasculature @PROTEIN$ functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and @COMPOUND$ diet.	1
1473	In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1
1474	Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1
1475	For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1476	For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
1477	For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0
1478	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
1479	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
1480	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
1481	For the case of xylose-proton symport, omitting the @PROTEIN$ (glucose-6-phosphate dehydrogenase) or PntAB (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1482	For the case of xylose-proton symport, omitting the Zwf (glucose-6-phosphate dehydrogenase) or @PROTEIN$ (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1483	Experimentally, deleting pgi (encoding @PROTEIN$) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1484	Experimentally, deleting @PROTEIN$ (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and pntA) has no significant effect on the measured yield.	1
1485	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (@PROTEIN$ and pntA) has no significant effect on the measured yield.	0
1486	Experimentally, deleting pgi (encoding phosphoglucose isomerase) from strain PC09 improves the yield from 3.4 to 4.0 mol @COMPOUND$ (mol glucose)(-1), while deleting either or both E. coli transhydrogenases (sthA and @PROTEIN$) has no significant effect on the measured yield.	0
1487	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
1488	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1489	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
1490	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
1491	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to @COMPOUND$.	1
1492	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes @COMPOUND$ at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.	1
1493	@COMPOUND$ served as the terminal electron acceptor of the reaction and was fully reduced to water by @PROTEIN$.	1
1494	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1495	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1496	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1497	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1498	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1499	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1500	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1501	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1502	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
1503	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
1504	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1505	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1506	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
1507	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
1508	The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1
1509	The cell proliferation, the up-regulation of pS2, and the down-regulation of @PROTEIN$ and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
1510	The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and @PROTEIN$ gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
1511	While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1
1512	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1513	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
1514	Prolonged L-alanine exposure induces changes in metabolism, @COMPOUND$+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	0
1515	Prolonged L-@COMPOUND$ exposure induces changes in metabolism, Ca(2+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	1
1516	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to alanine can induce reversible alterations to metabolic flux, @COMPOUND$+) handling and @PROTEIN$ secretion.	0
1517	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to @COMPOUND$ can induce reversible alterations to metabolic flux, Ca(2+) handling and @PROTEIN$ secretion.	1
1518	Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1
1519	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1520	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1521	Reaction parameters for the production of XOS from corncob using @PROTEIN$ from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% @COMPOUND$ was obtained.	0
1522	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
1523	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1524	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1525	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1526	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
1527	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through NOS inhibition and enhancement of @PROTEIN$ activity.	1
1528	These data support the idea that @COMPOUND$ may play a role in airway diseases, including asthma and pulmonary fibrosis, through @PROTEIN$ inhibition and enhancement of arginase activity.	1
1529	Osteopontin (@PROTEIN$) inhibits the growth of @COMPOUND$ (COM) and other crystal phases in a phosphorylation-dependent manner.	1
1530	Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% @COMPOUND$ at 7 d indicating a differential expression of @PROTEIN$ products.	1
1531	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
1532	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
1533	Here, we found that the addition of glucocorticoids, such as dexamethasone and @COMPOUND$, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
1534	Here, we found that the addition of glucocorticoids, such as @COMPOUND$ and cortisol, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
1535	Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1
1536	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1537	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1538	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1539	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1540	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1541	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1542	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1543	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1544	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1545	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1546	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1547	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1548	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1549	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1550	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1551	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1552	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1553	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1554	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1555	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1556	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1557	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1558	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1559	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1560	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1561	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1562	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1563	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1564	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1565	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1566	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1567	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1568	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1569	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1570	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1571	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1572	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1573	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1574	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1575	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1576	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1577	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1578	Rac1 (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired @PROTEIN$-, but not G-protein signaling, was responsible for the observed defect.	0
1579	@PROTEIN$ (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the @COMPOUND$) analog U46619, indicating that impaired GPVI-, but not G-protein signaling, was responsible for the observed defect.	0
1580	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
1581	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1582	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1583	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1584	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1585	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1586	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1587	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1588	Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1589	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1590	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1591	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
1592	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
1593	Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1
1594	@PROTEIN$ activity was also inhibited for all the soils treated with @COMPOUND$ (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.	1
1595	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
1596	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/@COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1597	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) @COMPOUND$ clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and somatostatin.	0
1598	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/L) glucose clamps were maintained for 6 hours by infusion of glucose, @PROTEIN$ and @COMPOUND$.	0
1599	or=6 ng/ml) was associated with increased expression of mrp-1 and @PROTEIN$ and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
1600	or=6 ng/ml) was associated with increased expression of mrp-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-@PROTEIN$.	0
1601	or=6 ng/ml) was associated with increased expression of @PROTEIN$-1 and pgp-1 and decreased @COMPOUND$, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-glycoproteins.	0
1602	@COMPOUND$+) also induces the release of the pro-apoptotic factors, @PROTEIN$ and AIF.	1
1603	@COMPOUND$+) also induces the release of the pro-apoptotic factors, cytochrome c and @PROTEIN$.	1
1604	Incubation of rat hepatocyte primary cultures with @COMPOUND$+) results in apoptosis induction with caspase activation and increased level of expression of @PROTEIN$.	1
1605	@COMPOUND$ reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein @PROTEIN$.	0
1606	@PROTEIN$ accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and @COMPOUND$.	0
1607	Bax accumulated in mitochondria in response to API-2, whereas release of @PROTEIN$ from mitochondria required both API-2 and @COMPOUND$.	1
1608	We suggest that @COMPOUND$ elicits events that activate Bax once it translocates to mitochondria and that inactivation of @PROTEIN$ signals these events and the down-regulation of XIAP.	1
1609	We suggest that @COMPOUND$ elicits events that activate @PROTEIN$ once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP.	1
1610	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher @PROTEIN$ content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1611	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, @PROTEIN$, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1612	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and @PROTEIN$ (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1613	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, @PROTEIN$, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1614	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (@PROTEIN$) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1615	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, @PROTEIN$, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1616	Moreover, @COMPOUND$ supplementation significantly increased both basal and @PROTEIN$ stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	0
1617	Moreover, @COMPOUND$ supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1618	Moreover, taurine supplementation significantly increased both basal and insulin stimulated @COMPOUND$ phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1619	Moreover, taurine supplementation significantly increased both basal and @PROTEIN$ stimulated @COMPOUND$ phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	1
1620	These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1621	These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1622	In addition, @COMPOUND$ enhances peripheral @PROTEIN$ sensitivity.	1
1623	Amino acids (@COMPOUND$, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1624	Amino acids (alanine, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when @COMPOUND$ (AC) was used as support.	0
1625	Amino acids (alanine, @COMPOUND$, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1626	The NSCs and neuroblasts had epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor alpha (@PROTEIN$) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1627	The NSCs and neuroblasts had @PROTEIN$ (EGFR) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1628	The NSCs and neuroblasts had epidermal growth factor receptor (@PROTEIN$) and platelet-derived growth factor receptor alpha (PDGFRalpha) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker @COMPOUND$.	0
1629	Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0
1630	Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0
1631	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
1632	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
1633	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1634	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1635	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1636	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1637	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-@PROTEIN$/CD86 interactions in CD4 (+) T lymphocytes.	1
1638	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/@PROTEIN$ interactions in CD4 (+) T lymphocytes.	1
1639	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte @PROTEIN$ (CD152)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
1640	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (@PROTEIN$)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
1641	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1
1642	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1
1643	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1
1644	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1
1645	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1
1646	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1
1647	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1648	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1649	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1650	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1651	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1652	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
1653	@COMPOUND$ decreased fasting glucose by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	1
1654	FSO decreased fasting @COMPOUND$ by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating @PROTEIN$, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	0
1655	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (@COMPOUND$) proposed as a likely health-promoting component.	0
1656	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with @COMPOUND$ (EGCG) proposed as a likely health-promoting component.	0
1657	Animal evidence indicates that @COMPOUND$ may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.	0
1658	The purpose of this study was to investigate the effect of dietary supplementation with @COMPOUND$ on @PROTEIN$ resistance and associated metabolic risk factors in man.	1
1659	@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1660	EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1661	In conclusion, regular intake of @COMPOUND$ had no effect on @PROTEIN$ resistance but did result in a modest reduction in diastolic blood pressure.	0
1662	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of @PROTEIN$ (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
1663	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), @PROTEIN$ (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
1664	@COMPOUND$ effect on HS cell viability was markedly reduced in hypoxic condition without an induction of chemoresistant related protein, P-@PROTEIN$.	0
1665	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0
1666	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
1667	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
1668	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1669	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1670	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1671	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1672	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1673	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1674	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1675	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1676	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1677	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1678	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1679	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1
1680	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1
1681	@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1682	@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1683	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
1684	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1685	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1686	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1687	The MEK inhibitor @COMPOUND$ did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1688	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of @COMPOUND$ on neurite outgrowth is independent of the ERK signaling pathway.	0
1689	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and @COMPOUND$ did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1690	Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1
1691	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds (CRLII).	1
1692	Effects on haemolytic activity of single @COMPOUND$ substitutions in the Bordetella pertussis @PROTEIN$ pore-forming fragment.	1
1693	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
1694	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
1695	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
1696	Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1
1697	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
1698	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1699	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1700	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of @PROTEIN$ (NOS) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
1701	NO, a gas, is produced from L-@COMPOUND$ by different isoforms of nitric oxide synthase (@PROTEIN$) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	1
1702	As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1703	As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1704	@PROTEIN$-@COMPOUND$ levels increase with age in American women but not in Hong Kong Chinese women.	1
1705	@PROTEIN$ (HDL) @COMPOUND$ is a powerful cardiovascular risk factor.	1
1706	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of @PROTEIN$, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1707	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and @PROTEIN$, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1708	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, @PROTEIN$, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1709	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, @PROTEIN$ and succinate dehydrogenase activities.	0
1710	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, @PROTEIN$, AcP, AlkP and GRD levels towards near normal.	0
1711	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, @PROTEIN$, CAT, AcP, AlkP and GRD levels towards near normal.	0
1712	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, @PROTEIN$, AlkP and GRD levels towards near normal.	0
1713	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, AcP, AlkP and @PROTEIN$ levels towards near normal.	0
1714	@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0
1715	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to @COMPOUND$ (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1716	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (@COMPOUND$) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1717	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary @COMPOUND$ (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1718	A role for @PROTEIN$ in @COMPOUND$-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.	0
1719	We induced fever in Pekin ducks with @COMPOUND$ and, at the same time, treated the animals with @PROTEIN$ antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.	0
1720	Here, we proposed that @PROTEIN$, a vacuolar amino peptidase, is involved in glutathione catabolism under @COMPOUND$ stress.	1
1721	Thus, under cadmium stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient @COMPOUND$ turnover stored in the vacuole.	1
1722	Thus, under @COMPOUND$ stress, @PROTEIN$ and gamma-glutamyl transferase seem to work together to assure an efficient glutathione turnover stored in the vacuole.	1
1723	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1724	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1725	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), @PROTEIN$ (phox), and Nox4.	1
1726	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like @PROTEIN$ (phox), p47 (phox), and Nox4.	1
1727	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and @PROTEIN$.	1
1728	We conclude that mitochondrial dysfunction can induce @PROTEIN$ oligomerization via @COMPOUND$ depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.	1
1729	Activation of c-@PROTEIN$ N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by @COMPOUND$.	1
1730	Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1731	Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0
1732	Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1733	Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0
1734	Induction in the activity of @PROTEIN$ and azoreductase was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
1735	Induction in the activity of lignin peroxidase and @PROTEIN$ was observed during decolorization of @COMPOUND$ in the batch culture, which represented their role in degradation.	1
1736	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
1737	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1738	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1739	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1740	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1741	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1742	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1743	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1744	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1745	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1746	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1747	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1748	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1749	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1750	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1751	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0
1752	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1753	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1754	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1755	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0
1756	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1757	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1758	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1759	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1760	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1761	The pERE@PROTEIN$9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of @COMPOUND$, which is an antagonist of estrogen, was observed using the GFP expression level.	0
1762	By @COMPOUND$ treatment, the fluorescence intensity of the @PROTEIN$ was decreased by 30-50% within 24h.	1
1763	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-@COMPOUND$ to l-ornithine and urea.	1
1764	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to l-ornithine and @COMPOUND$.	1
1765	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to @COMPOUND$ and urea.	1
1766	To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces @COMPOUND$, as a source of @PROTEIN$ (Xyl3).	1
1767	We examined the effects of plasmid-based expression of Xyl3 versus @PROTEIN$ on growth and @COMPOUND$ production by engineered E. coli strains.	0
1768	Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of @PROTEIN$, @COMPOUND$, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.	0
1769	In this study, a representative FRET system (@PROTEIN$ donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1770	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (@PROTEIN$ (2)) acceptor and @COMPOUND$ substrate).	0
1771	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla @PROTEIN$ donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1772	In this study, a representative FRET system (CFP donor and @PROTEIN$ acceptor) is compared with the BRET(2) system (Renilla luciferase donor, green fluorescent protein (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1773	In this study, a representative FRET system (CFP donor and YFP acceptor) is compared with the BRET(2) system (Renilla luciferase donor, @PROTEIN$ (2) (GFP (2)) acceptor and @COMPOUND$ substrate).	0
1774	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1
1775	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1
1776	@COMPOUND$ inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of @PROTEIN$ in rat mesangial cells.	1
1777	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
1778	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
1779	Transitions in the @COMPOUND$ microenvironment and secondary structure of two monocot @PROTEIN$ from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	0
1780	The @PROTEIN$ exist as tetramers with a single @COMPOUND$ residue estimated per monomer, present in a polar environment.	1
1781	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-@COMPOUND$ or 6 M Urea or at pH 2.0 and below.	1
1782	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M @COMPOUND$ or at pH 2.0 and below.	1
1783	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M @COMPOUND$-HCl or 6 M Urea or at pH 2.0 and below.	1
1784	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1785	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1786	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1787	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (@PROTEIN$) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1788	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (@PROTEIN$) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1789	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1790	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1791	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1792	The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1
1793	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
1794	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
1795	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
1796	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
1797	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/@PROTEIN$ at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1
1798	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) @PROTEIN$, (ii) phosphorylation and degradation of IkappaBalpha, (iii) phosphorylation of NF-kappaB/p65 at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1
1799	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with @COMPOUND$ resulted in the inhibition of (i) IKKalpha, (ii) phosphorylation and degradation of @PROTEIN$, (iii) phosphorylation of NF-kappaB/p65 at Ser (536), (iv) nuclear translocation of NF-kappaB/p65, (v) NF-kappaB/p65 DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	1
1800	Accommodation of @COMPOUND$ and its analogues by @PROTEIN$ is dominated by hydrophobic interactions.	1
1801	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, @COMPOUND$ and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1802	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates pyridostigmine, rivastigmine and several analogues of @COMPOUND$, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1803	The role of the functional architecture of the HuAChE (human @PROTEIN$) in reactivity toward the carbamates @COMPOUND$, rivastigmine and several analogues of physostigmine, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	1
1804	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0
1805	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0
1806	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0
1807	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1808	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0
1809	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1810	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1811	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1812	We examined the expression of @PROTEIN$ and ASCT1 in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
1813	We examined the expression of Phgdh and @PROTEIN$ in @COMPOUND$ (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	1
1814	In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1
1815	A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1
1816	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of @PROTEIN$ (GP) and are mainly destined to serve as substrates for the generation of @COMPOUND$.	0
1817	The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1818	The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1819	The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1820	The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1821	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1822	The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1823	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1824	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1825	Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G&gt;C with circulating @COMPOUND$ levels, @PROTEIN$ levels, and body mass index.	0
1826	Joint analysis of individual participants' data from 17 studies on the association of the @PROTEIN$ variant-174G&gt;C with circulating @COMPOUND$ levels, interleukin-6 levels, and body mass index.	0
1827	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary @PROTEIN$ (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1828	Differences in the expression of inwardly rectifying potassium channels (@PROTEIN$), glial fibrillary acidic protein (GFAP), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1829	Differences in the expression of inwardly rectifying potassium channels (Kir4.1), glial fibrillary acidic protein (@PROTEIN$), and @COMPOUND$ levels in cortical astrocytes were detected using immunohistochemical methods.	0
1830	Immunohistochemical analysis suggests that the diverse expression of @PROTEIN$ channels and GFAP as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0
1831	Immunohistochemical analysis suggests that the diverse expression of Kir4.1 channels and @PROTEIN$ as well as differences in the accumulation of @COMPOUND$ might contribute to the distinct ability of astrocytes to regulate their volume.	0
1832	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by @COMPOUND$ chloride (5 microg).	1
1833	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by @COMPOUND$ (5 microg) or @PROTEIN$ was inhibited by chelerythrine chloride (5 microg).	0
1834	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by chelerythrine @COMPOUND$ (5 microg).	1
1835	Regulation of the phosphoinositide-3 kinase and @PROTEIN$ signaling pathways by @COMPOUND$ and its reduced metabolites in the rat brain.	1
1836	Several growth factors, such as vascular endothelial growth factor, @PROTEIN$, and insulin-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1837	Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and @PROTEIN$-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1838	Significant increases in the phosphorylation of @PROTEIN$, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1839	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (@PROTEIN$) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1840	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (@PROTEIN$) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1841	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of @PROTEIN$ were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1842	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of @PROTEIN$ and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1843	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
1844	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
1845	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
1846	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
1847	@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1
1848	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1849	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1850	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1851	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1852	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1853	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1854	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1855	Identification of @PROTEIN$ as a candidate gene for regulation of responsiveness to dietary @COMPOUND$ in rats.	1
1856	Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of @PROTEIN$, as a strong candidate for responsiveness to dietary @COMPOUND$.	1
1857	@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1
1858	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0
1859	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0
1860	@COMPOUND$ (GSH), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
1861	Glutathione (@COMPOUND$), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
1862	Glutathione (GSH), catalase (@PROTEIN$), and @COMPOUND$ (MDA) activities in blood were measured.	0
1863	Glutathione (@COMPOUND$), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
1864	Glutathione (GSH), @PROTEIN$ (CAT), and @COMPOUND$ (MDA) activities in blood were measured.	0
1865	@COMPOUND$ (GSH), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
1866	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1867	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1868	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1869	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1870	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1871	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1872	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
1873	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
1874	To investigate any similarities in the inhibition of @PROTEIN$ by quinacrine and @COMPOUND$, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where disulfiram is also attached.	1
1875	administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and catalase (@PROTEIN$) activity depression to control levels.	1
1876	administered during 7 days at 20 mg/kg per day (subacute treatment), @COMPOUND$ abrogated LPS-induced erythrocytes lipoperoxidation and @PROTEIN$ (CAT) activity depression to control levels.	1
1877	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
1878	The influence of carbon sources on rhGH (recombinant human @PROTEIN$) production by two Pichia pastoris strains having different @COMPOUND$ utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	0
1879	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-@PROTEIN$/c-jun heterodimers in spontaneous hypertensive rats (SHRs).	1
1880	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-@PROTEIN$ heterodimers in spontaneous hypertensive rats (SHRs).	1
1881	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0
1882	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0
1883	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1884	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1885	These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1
1886	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1887	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1888	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
1889	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1890	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1891	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
1892	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1893	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
1894	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
1895	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
1896	The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1897	The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1898	The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1899	@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of Cdk5/@PROTEIN$.	1
1900	@COMPOUND$, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of @PROTEIN$/p35.	1
1901	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1902	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1903	Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1904	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1905	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1906	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1907	Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1
1908	@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0
1909	@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0
1910	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (@PROTEIN$)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1911	We found previously that increased levels of polyamine oxidase (@PROTEIN$) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1912	We found previously that increased levels of @PROTEIN$ (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1913	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus @PROTEIN$ (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1914	We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0
1915	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), @PROTEIN$ (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1916	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (@PROTEIN$) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1917	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (@PROTEIN$) were significantly higher in SBI than in normal subjects.	0
1918	Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1
1919	Catalepsy, serum @PROTEIN$, receptor binding profile and cortical (PFC), hippocampal (Hip) and @COMPOUND$ (DA) levels were determined.	0
1920	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of SOD, @COMPOUND$-Px, @PROTEIN$ and MDA.	0
1921	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of @PROTEIN$, @COMPOUND$-Px, CAT and MDA.	0
1922	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of SOD, @COMPOUND$-Px, @PROTEIN$, and reduced MDA in body.	0
1923	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of @PROTEIN$, @COMPOUND$-Px, CAT, and reduced MDA in body.	0
1924	A novel @COMPOUND$-specific @PROTEIN$ from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	1
1925	A novel @PROTEIN$ (PCL) with specificity towards @COMPOUND$ was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	1
1926	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
1927	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
1928	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
1929	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
1930	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
1931	Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1932	@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1933	The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0
1934	The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0
1935	The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0
1936	The objective of the present study was to investigate the effects of a high-@COMPOUND$ diet on @PROTEIN$ expression and IR localization and activity in the rat liver.	1
1937	Immobilization of @PROTEIN$ on the @COMPOUND$ modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	1
1938	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing @PROTEIN$ on the @COMPOUND$ modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	1
1939	Involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1940	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during @COMPOUND$-induced erythroid differentiation of K562 erythroleukemia cells.	0
1941	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, @COMPOUND$ (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.	1
1942	Taken together, our results suggested the involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1943	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant @PROTEIN$ and over-expressed EGFR.	1
1944	In vitro effect of radiation, antibody to epidermal growth factor receptor and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed @PROTEIN$.	1
1945	In vitro effect of radiation, antibody to @PROTEIN$ and @COMPOUND$ in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.	0
1946	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1947	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1948	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1949	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
1950	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
1951	Loss-of-expression of @PROTEIN$ in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of @COMPOUND$ analog treatment in some clinical trials.	1
1952	Activities of malate- and succinate-dehydrogenases (MDH, @PROTEIN$) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1953	Activities of malate- and succinate-dehydrogenases (@PROTEIN$, SDH) and NADH- and succinate-cytochrome c reductases (NCCR, SCCR) were rapidly inhibited, while cytochrome c oxidase (CCO) was unaltered by @COMPOUND$ treatment.	1
1954	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1955	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1956	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1957	We therefore propose @COMPOUND$-dependent homodimerization to be an essential step in the regulation of @PROTEIN$-dependent transcription.	1
1958	In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1
1959	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-@PROTEIN$-2a (180 microg/week) and @COMPOUND$ (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	0
1960	Thus in HCV-2- and HCV-3-infected patients, withdrawal of @COMPOUND$ and continuation of Peg-@PROTEIN$-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	0
1961	Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1
1962	Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1
1963	Thus, in keeping with the ability of neurosteroids to potentiate @COMPOUND$ currents via a broad variety of @PROTEIN$ isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	1
1964	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1965	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
1966	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1967	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1968	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1969	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1970	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1971	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1972	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1973	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1974	Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1
1975	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1976	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood @COMPOUND$ levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total cholesterol) with neutral effect on body weight.	0
1977	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the @PROTEIN$ (1c), non-fasting plasma insulin, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1978	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the hemoglobin A (1c), non-fasting plasma @PROTEIN$, fasting blood glucose levels, glucose intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total @COMPOUND$) with neutral effect on body weight.	0
1979	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
1980	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (@COMPOUND$) of Ascaris suum fused with cholera @PROTEIN$ subunit.	0
1981	Inhibition of human poly(A)-specific @PROTEIN$ (PARN) by @COMPOUND$ nucleotides: kinetic analysis.	1
1982	Inhibition of human poly(A)-specific ribonuclease (@PROTEIN$) by @COMPOUND$ nucleotides: kinetic analysis.	1
1983	Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0
1984	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type @PROTEIN$ (Cu,Zn-superoxide dismutase) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1985	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-@PROTEIN$) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1986	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by @PROTEIN$ active-site @COMPOUND$.	1
1987	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1
1988	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1989	Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1990	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0
1991	Imidazoline-induced amplification of glucose- and @COMPOUND$-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1992	Imidazoline-induced amplification of @COMPOUND$- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1993	@COMPOUND$-induced amplification of glucose- and carbachol-stimulated @PROTEIN$ release includes a marked suppression of islet nitric oxide generation in the mouse.	1
1994	The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
1995	The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
1996	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or @COMPOUND$, while mRNA for @PROTEIN$ remained essentially unchanged.	0
1997	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by @COMPOUND$ or picrotoxin, while mRNA for @PROTEIN$ remained essentially unchanged.	0
1998	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
1999	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
2000	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1
2001	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1
2002	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of @PROTEIN$-@COMPOUND$ to activate mTORC1.	1
2003	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2004	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
2005	"Iron uptake by the ubiquitous iron-storage protein ferritin involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" @PROTEIN$ centre"" in individual subunits."	1
2006	"Iron uptake by the ubiquitous iron-storage protein @PROTEIN$ involves the oxidation of two @COMPOUND$) ions located at the highly conserved dinuclear "" ferroxidase centre"" in individual subunits."	1
2007	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
2008	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
2009	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
2010	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
2011	The aim of this study was to determine the effect of @COMPOUND$ on endothelial function in anti-tumour necrosis factor (@PROTEIN$)-naive RA patients.	1
2012	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone @PROTEIN$ (BMP).	0
2013	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone morphogenetic protein (@PROTEIN$).	0
2014	The cells were mixed with @COMPOUND$ (beta-TCP) granules followed by osteoblast induction with recombinant human @PROTEIN$ (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	0
2015	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2016	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2017	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
2018	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2019	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
2020	We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0
2021	Zn2+-linked dimerization of @PROTEIN$ from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and urease activation.	1
2022	Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and @PROTEIN$ activation.	0
2023	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a @COMPOUND$-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2024	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two @COMPOUND$+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2025	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-@COMPOUND$ functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
2026	Residue-wise conformational stability of @PROTEIN$ dimer from native-state @COMPOUND$ exchange.	1
2027	Whereas the role of locally produced 1, @COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
2028	Whereas the role of locally produced 1, 25-dihydroxy@COMPOUND$ is not yet clear, it is possible that it contributes importantly to vitamin D-mediated inhibition of parathyroid cell growth, so @PROTEIN$ can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	0
2029	Mechanistically, we showed EphA2 knockdown suppressed @PROTEIN$-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.	1
2030	Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of @PROTEIN$ transcriptional upregulation.	1
2031	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
2032	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
2033	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
2034	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
2035	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
2036	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by @PROTEIN$ (CYP11A).	1
2037	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
2038	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by @PROTEIN$ (CYP11A).	1
2039	Finally, HA increased @PROTEIN$ (NOS) activity, and the NOS inhibitor NG-nitro-@COMPOUND$ (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.	0
2040	@PROTEIN$ activity and @COMPOUND$ levels may therefore be altered in 22q11DS individuals.	0
2041	@PROTEIN$ (158) genotype and plasma @COMPOUND$ levels were determined in the 22q11DS children.	0
2042	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma @PROTEIN$, and body weight for up to 21 d postdose.	1
2043	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood @PROTEIN$ content, plasma cholinesterases, and body weight for up to 21 d postdose.	1
2044	Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1
2045	Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1
2046	@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1
2047	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or @COMPOUND$ (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with @PROTEIN$ (OVA).	0
2048	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2049	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2050	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2051	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2052	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2053	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2054	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2055	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2056	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
2057	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
2058	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2059	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
2060	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
2061	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
2062	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
2063	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess @COMPOUND$ production either by @PROTEIN$ or complex III.	1
2064	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
2065	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
2066	Effects of conjugated linoleic acid plus n-3 @COMPOUND$ on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
2067	Effects of @COMPOUND$ plus n-3 polyunsaturated fatty acids on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
2068	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1
2069	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (@COMPOUND$).	1
2070	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-@COMPOUND$) triphosphate (AMPCPP).	1
2071	To identify the amino-acid residues that contribute to @PROTEIN$ activity, we prepared six mutants of SPS and examined their @COMPOUND$-dependent ATP consumption.	1
2072	"In @PROTEIN$. @COMPOUND$, the N-terminal loop, including the two residues, assumes different conformations (""open"" and ""closed"") between the two subunits."	1
2073	Effect of obestatin on insulin, @PROTEIN$ and @COMPOUND$ secretion in the perfused rat pancreas.	0
2074	Effect of @PROTEIN$ on insulin, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	1
2075	Effect of obestatin on @PROTEIN$, glucagon and @COMPOUND$ secretion in the perfused rat pancreas.	0
2076	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2077	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2078	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2079	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
2080	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2081	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2082	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2083	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
2084	We administered @COMPOUND$ to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable @PROTEIN$ inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	1
2085	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
2086	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
2087	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
2088	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
2089	We also assess prostaglandin (@PROTEIN$ (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
2090	We also assess prostaglandin (@PROTEIN$ (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
2091	High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, @PROTEIN$, and @COMPOUND$ for the latter agranulocytosis were successfully performed.	0
2092	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2093	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
2094	The relative gene expression of @PROTEIN$ 0.05) in-@COMPOUND$ calves compared with+ Cu or-Cu+Mn calves.	1
2095	The study was prompted to characterize the B-type @PROTEIN$ activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and @COMPOUND$ pesticides.	1
2096	Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with @COMPOUND$ (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and 1-naphthyl acetate (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1
2097	Specific @PROTEIN$ and carboxylesterase activities were mainly obtained with acetylthiocholine (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and @COMPOUND$ (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	1
2098	To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of @COMPOUND$ were evaluated on recombinant @PROTEIN$ expressed in HEK293T cells.	1
2099	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2100	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2101	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, @PROTEIN$, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2102	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2103	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2104	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2105	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2106	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2107	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2108	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2109	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2110	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2111	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2112	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2113	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2114	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2115	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2116	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
2117	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2118	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2119	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2120	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
2121	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2122	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
2123	@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0
2124	Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1
2125	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
2126	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
2127	Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, @COMPOUND$, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0
2128	Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-@COMPOUND$, doxorubicin, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0
2129	Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, @COMPOUND$, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0
2130	Other factors prognostic for inferior survival were @PROTEIN$ 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, vincristine, and @COMPOUND$ chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	0
2131	Association between @COMPOUND$ (247) polymorphism of @PROTEIN$ and cerebral infarction in a Chinese population.	1
2132	The purpose of this study was to identify associations between the @COMPOUND$ (247) polymorphism of @PROTEIN$ gene and CI in a Chinese cohort.	1
2133	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
2134	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the @COMPOUND$ with GSH.	0
2135	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the platinum complex with @COMPOUND$.	0
2136	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
2137	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
2138	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) by inflammatory, anti-inflammatory and apoptotic factors.	0
2139	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of @PROTEIN$ (3beta-HSD) by inflammatory, anti-inflammatory and apoptotic factors.	0
2140	Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1
2141	@PROTEIN$ dehydrogenase activity was observed in H4IIE cells only at subphysiological @COMPOUND$ levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	1
2142	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., @COMPOUND$) and immune function indicators, especially lymphocyte proliferation and @PROTEIN$ cytokine production.	0
2143	TCblR belongs to the @PROTEIN$ family, with 2 low-density lipoprotein receptor type A domains separated by a complement-like @COMPOUND$-rich region.	1
2144	TCblR belongs to the low-density lipoprotein receptor family, with 2 low-density lipoprotein receptor @PROTEIN$ domains separated by a complement-like @COMPOUND$-rich region.	1
2145	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2146	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2147	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
2148	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
2149	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
2150	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
2151	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
2152	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
2153	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
2154	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
2155	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
2156	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1
2157	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1
2158	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
2159	First, R-state, or allosteric, autocatalysis of nitrite reduction increases the rate of NO generation by deoxy@PROTEIN$ and results in maximal NO production at approximately 50% hemoglobin @COMPOUND$ saturation, which is physiologically associated with greatest NO-dependent vasodilation.	1
2160	Role of @PROTEIN$ and Nox2 in hyperoxia-induced reactive @COMPOUND$ species generation and migration of human lung endothelial cells.	1
2161	Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0
2162	Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0
2163	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein @COMPOUND$ (LDL-C) and non-@PROTEIN$ cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	0
2164	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
2165	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
2166	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2167	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2168	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2169	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced @PROTEIN$ expression.	1
2170	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced @PROTEIN$ expression.	1
2171	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2172	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
2173	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
2174	@PROTEIN$ blockade normalizes hippocampal alterations and cognitive impairment in @COMPOUND$-induced type 1 diabetes mice.	1
2175	Quantitative evaluation of @PROTEIN$ contribution to oral absorption of @COMPOUND$ in rats.	1
2176	We previously reported that inhibition of @PROTEIN$-kinase (ROCK) by hydroxyl @COMPOUND$ improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	1
2177	Finally, in the presence of OGD and @COMPOUND$ mesylate, superoxide dismutase (@PROTEIN$) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2178	Finally, in the presence of OGD and @COMPOUND$ mesylate, @PROTEIN$ (SOD) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	1
2179	Na+/H+ exchanger isoform 3 (@PROTEIN$) is responsible for net uptake of @COMPOUND$ and water from the gastrointestinal (GI) tract.	1
2180	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
2181	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
2182	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2183	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
2184	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
2185	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
2186	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
2187	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
2188	@PROTEIN$ enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of @COMPOUND$ and synthesis of plant hormones.	1
2189	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to aspartic acid and @COMPOUND$ by @PROTEIN$.	1
2190	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to @COMPOUND$ and ammonia by @PROTEIN$.	1
2191	The mitochondrial membrane potential (Delta psi (mit)) was also tested with @COMPOUND$ 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to @PROTEIN$.	1
2192	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0
2193	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
2194	Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0
2195	Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0
2196	Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0
2197	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
2198	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
2199	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2200	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard apolipoprotein A-I (@PROTEIN$), HDL(2), and serum was measured.	1
2201	Cholesterol efflux from ((3)H) @COMPOUND$-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2202	@COMPOUND$ efflux from ((3)H) cholesterol-oleate-acetyl-LDL-loaded monocyte-derived macrophages to standard @PROTEIN$ (apoA-I), HDL(2), and serum was measured.	1
2203	@COMPOUND$ efflux to @PROTEIN$, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	0
2204	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), @PROTEIN$ (P = 0.004), apoA-II 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
2205	@COMPOUND$ efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), apoA-I (P = 0.004), @PROTEIN$ 0.0001), and the percentage of apoA-I present in the form of prebeta-HDL (P = 0.0001).	1
2206	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
2207	Regulation of muscle protein degradation, not synthesis, by dietary @COMPOUND$ in rats fed @PROTEIN$-deficient diet.	0
2208	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2209	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
2210	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1
2211	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2212	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
2213	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2214	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
2215	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0
2216	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0
2217	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of @PROTEIN$/HDAC3.	0
2218	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of HDAC1/@PROTEIN$.	0
2219	This process is associated with an increase in intracellular levels of @COMPOUND$, increase in the acetylation status of @PROTEIN$, and enhanced cell death.	0
2220	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
2221	Epigenetic reprogramming of breast cancer cells by @COMPOUND$ occurs regardless of @PROTEIN$ status.	0
2222	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
2223	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
2224	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
2225	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
2226	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
2227	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
2228	In this review we discuss the @PROTEIN$ that transport arsenic and @COMPOUND$ into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	1
2229	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
2230	We report that the PP inhibition of proteolysis in young rats was mediated by the increased @PROTEIN$ secretion and resulted from a down-regulation of both lysosomal and @COMPOUND$+)-dependent proteolysis.	0
2231	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2232	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
2233	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2234	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
2235	The results showed that pancreatic @COMPOUND$ content and @PROTEIN$.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
2236	The results showed that pancreatic selenium content and @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
2237	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2238	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2239	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
2240	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with @COMPOUND$ or ferrous ions or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
2241	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or ferrous ions or by exposure to auto-oxidation products of @COMPOUND$ for 16h, and @PROTEIN$ was then assayed in medium.	0
2242	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or @COMPOUND$ or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
2243	In hypersensitive alpha4L9'A mice, injections of a low dose of @COMPOUND$ (0.1 mg/kg) led to strong c-@PROTEIN$ expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	1
2244	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal @PROTEIN$ precursors, GAD67, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
2245	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, GAD67, @PROTEIN$) by quantitative in situ hybridization histochemistry.	1
2246	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of @COMPOUND$-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal neuropeptide precursors, @PROTEIN$, cytochrome oxidase subunit I) by quantitative in situ hybridization histochemistry.	1
2247	"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1
2248	This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0
2249	@COMPOUND$ plus low-dose trastuzumab in @PROTEIN$ positive metastatic breast cancer.	0
2250	This phase II study, evaluated the activity and cardiotoxicity of first-line @COMPOUND$ plus low-dose trastuzumab (LD-T) in patients with @PROTEIN$ positive MBC.	0
2251	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2252	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
2253	Promoter analysis of the @PROTEIN$, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to @COMPOUND$ in their 5'-flanking sequences.	0
2254	@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1
2255	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
2256	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
2257	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
2258	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0
2259	A critical requirement for this mechanism is that @COMPOUND$ must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the @PROTEIN$.	0
2260	Efficacy, safety and patient-reported outcomes of combination @PROTEIN$ and @COMPOUND$ versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	0
2261	To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0
2262	A randomized trial of @COMPOUND$ and @PROTEIN$ with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.	0
2263	Twenty seven patients were mobilized with @COMPOUND$ and @PROTEIN$ and 28 with etoposide, G-CSF and rituximab.	0
2264	Aberrant methylation of the @PROTEIN$ (O6-methylguanine-DNA methyltransferase) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., @COMPOUND$) in malignant gliomas.	1
2265	This work describes the influence of two polar lipids, Sn-1/3 and Sn-@COMPOUND$, on the activity of @PROTEIN$ in biphasic systems and in microemulsions.	1
2266	In previous communications, we have shown that Sn-@COMPOUND$ can replace Sn-1,3 regiospecific @PROTEIN$ at the oil-water interface, causing a drastically reduced rate of lipolysis.	1
2267	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2268	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2269	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2270	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
2271	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1
2272	Based on the preclinical evidence of @PROTEIN$ I (Topo-1) upregulation by @COMPOUND$ (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	1
2273	Wet-wrap treatment using dilutions of @COMPOUND$ ointment and fluticasone propionate cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2274	Wet-wrap treatment using dilutions of tacrolimus ointment and @COMPOUND$ cream in human @PROTEIN$ (+/+) mice with atopic dermatitis.	0
2275	The use of low-dose COCs is preferable in PCOS, especially among patients with @COMPOUND$ intolerance, @PROTEIN$ resistance and uncomplicated diabetes mellitus.	0
2276	Due to its faculty to protect @PROTEIN$ (ChE) activity against irreversible inactivation by OP, @COMPOUND$ (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	1
2277	Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1
2278	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
2279	We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2280	We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
2281	In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1
2282	In contrast, Notch-signaling inhibition by the @COMPOUND$ (GSI ; z-Leu-Leu-Nle-CHO) and the specific @PROTEIN$ down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	0
2283	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
2284	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
2285	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
2286	Effects of nonspecific targeting of @PROTEIN$ were evaluated with addition of imatinib (@COMPOUND$) to cell cultures.	0
2287	In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0
2288	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific @PROTEIN$ (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II RIPs, SNA-V), found in the same species.	1
2289	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II @PROTEIN$ (Type-II RIPs, SNA-V), found in the same species.	0
2290	Bark of elderberry (Sambucus nigra) contains a galactose (Gal)/N-acetylgalactosamine (@COMPOUND$)-specific lectin (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II ribosome-inactivating protein (Type-II @PROTEIN$, SNA-V), found in the same species.	0
2291	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene.	1
2292	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene, rendered phenotypically apparent with exposure to anesthetics.	1
2293	Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1
2294	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
2295	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
2296	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
2297	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
2298	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
2299	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
2300	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
2301	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
2302	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
2303	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of @COMPOUND$ and inducible @PROTEIN$ in the liver.	0
2304	Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0
2305	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2306	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2307	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2308	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2309	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2310	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2311	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2312	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2313	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
2314	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
2315	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
2316	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
2317	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2318	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2319	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2320	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
2321	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
2322	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
2323	In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0
2324	In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0
2325	Cell fractionation by @COMPOUND$ gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, @PROTEIN$ localized in fractions corresponding to caveolae.	0
2326	However, there are conflicting data regarding the role of Gpr30 as an @PROTEIN$ (ER): several laboratories were unable to demonstrate @COMPOUND$ binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.	0
2327	Our data demonstrate that in vivo @PROTEIN$ is dispensable for the mediation of @COMPOUND$ effects in reproductive organs.	0
2328	@COMPOUND$ modulation of alpha-, @PROTEIN$, and the norepinephrine transporter in an animal model of depression.	1
2329	@COMPOUND$ modulation of alpha-, gamma-synuclein, and the @PROTEIN$ in an animal model of depression.	1
2330	The @PROTEIN$-selective antidepressant @COMPOUND$ (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	1
2331	@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1
2332	@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1
2333	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of cyclin-dependent kinase 1 (@PROTEIN$) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
2334	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of @PROTEIN$ (Cdk1) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
2335	Knockdown of Bax and @PROTEIN$ proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
2336	Knockdown of @PROTEIN$ and Bak proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
2337	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
2338	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
2339	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2340	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2341	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
2342	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
2343	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (@PROTEIN$), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2344	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), @PROTEIN$ (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2345	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (@PROTEIN$), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2346	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (@PROTEIN$) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2347	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and @PROTEIN$ (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2348	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), @PROTEIN$ (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2349	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (@PROTEIN$), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2350	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (@PROTEIN$), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2351	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: @PROTEIN$ (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2352	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol @PROTEIN$ (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
2353	It could results from the fact that phenolic compounds (@COMPOUND$), which could be also substrates for different @PROTEIN$, were the first line of defence against metal stress.	1
2354	The affinity characteristics of developed immunosensors were investigated in reaction with @COMPOUND$, and @PROTEIN$.	1
2355	The detection limit for @COMPOUND$ was 10 ngmL(-1) and for @PROTEIN$ 0.01 ngmL(-1).	0
2356	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, @PROTEIN$ and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2357	This was achieved by (1) direct comparison of the sensitivity of ASIC1, @PROTEIN$, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2358	This was achieved by (1) direct comparison of the sensitivity of @PROTEIN$, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2359	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and @PROTEIN$ knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
2360	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2361	Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2362	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
2363	Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
2364	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2365	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2366	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2367	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
2368	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2369	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2370	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2371	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
2372	In addition, serum levels of @COMPOUND$, adiponectin, and @PROTEIN$ were measured.	0
2373	In addition, @COMPOUND$-activated @PROTEIN$ levels were high during fasting and low during HF diet.	1
2374	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0
2375	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1
2376	@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1
2377	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-@COMPOUND$ (LDL-c) and apolipoprotein-B100 (@PROTEIN$), making it difficult to disentangle their independent contributions to cardiovascular risk.	0
2378	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0
2379	After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0
2380	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
2381	Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0
2382	@COMPOUND$) was injected into pregnant mice 3 hr after the @PROTEIN$ administration to label the neural progenitor cells.	0
2383	A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0
2384	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
2385	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
2386	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of @COMPOUND$ (11-MUA) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
2387	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-@COMPOUND$) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
2388	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and 6-mercaptohexan-1-ol (6-@COMPOUND$) as adhesive layer.	0
2389	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and @COMPOUND$ (6-MHO) as adhesive layer.	0
2390	@COMPOUND$ is a potent glucocorticoid with high affinity for the @PROTEIN$, which is now used for the treatment of inflammatory bowel diseases.	1
2391	Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0
2392	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0
2393	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0
2394	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2395	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
2396	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1
2397	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1
2398	Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1
2399	We also found an inhibitory effect of @COMPOUND$ on the associations between cadherin 5, @PROTEIN$ and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	1
2400	We also found a strong inhibitory effect of @COMPOUND$ on hypoxia-induced endothelial cell formation of cords and @PROTEIN$ expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	1
2401	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
2402	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
2403	Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0
2404	Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1
2405	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in glutaredoxin (Grx) and @PROTEIN$ (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
2406	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in @PROTEIN$ (Grx) and glutathione peroxidase (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
2407	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2408	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2409	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2410	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2411	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2412	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2413	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2414	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2415	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2416	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2417	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2418	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2419	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2420	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
2421	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2422	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
2423	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
2424	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
2425	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
2426	Study of multiple binding constants of @COMPOUND$ with human @PROTEIN$ by capillary electrophoresis-frontal analysis and multivariate regression.	1
2427	In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of @COMPOUND$ (DXM), the interaction between DXM and @PROTEIN$ was studied by capillary electrophoresis-frontal analysis (CE-FA).	1
2428	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (@COMPOUND$ ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
2429	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by @COMPOUND$ (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
2430	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen @COMPOUND$ and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
2431	Enzymatic activities of an H(2)O(2) independent oxidase along with @PROTEIN$ and an azoreductase suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
2432	Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an @PROTEIN$ suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
2433	@PROTEIN$ activity was prominent in presence of cofactors @COMPOUND$ and NADP in mineral salt medium.	1
2434	@PROTEIN$ activity was prominent in presence of cofactors NADH and @COMPOUND$ in mineral salt medium.	1
2435	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
2436	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2437	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
2438	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2439	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
2440	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1
2441	In the present study, the mRNA expression and promoter @COMPOUND$ methylation of @PROTEIN$ isoforms (i.e.	0
2442	The present study is the first report that demonstrates selective inactivation of @PROTEIN$ isoforms through the promoter @COMPOUND$ methylation pathway in leukaemias.	1
2443	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of @PROTEIN$ and Akt : a downstream modulator of cell growth and survival.	1
2444	This study was performed to evaluate the effects of @COMPOUND$ on breast cancer cell lines with respect to the activity of PDGFR beta and @PROTEIN$ : a downstream modulator of cell growth and survival.	1
2445	The mechanisms may include the recently revealed anti-inflammatory effects of @PROTEIN$ as well as its conventional @COMPOUND$ and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	1
2446	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-@PROTEIN$-@COMPOUND$ system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	1
2447	The function of rhamnose-binding @PROTEIN$ in innate immunity by restricted binding to @COMPOUND$.	1
2448	This is the first finding that @COMPOUND$ plays a role in innate immunity by cooperating with natural ligands, @PROTEIN$.	1
2449	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
2450	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
2451	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2452	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2453	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2454	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
2455	A @PROTEIN$ (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/@COMPOUND$ source.	0
2456	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2457	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2458	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2459	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2460	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2461	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2462	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2463	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2464	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2465	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2466	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2467	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2468	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2469	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2470	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2471	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2472	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2473	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2474	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2475	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2476	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2477	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
2478	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2479	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
2480	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2481	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2482	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
2483	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
2484	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with @COMPOUND$, or toluidine blue staining.	0
2485	Hepatocyte apoptosis was estimated morphologically using @PROTEIN$ combined with propidium iodide, or @COMPOUND$ staining.	0
2486	The FFA fractions elicited pro-inflammatory responses inducing @PROTEIN$ and intracellular adhesion molecule expression and reactive @COMPOUND$ species (ROS) production in human aortic endothelial cells (HAECs).	0
2487	@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1
2488	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and @PROTEIN$/Ras/ERK1/2.	0
2489	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/@PROTEIN$/ERK1/2.	0
2490	Two principal signaling pathways that regulate proliferation are @PROTEIN$/@COMPOUND$/Akt and Shc/Ras/ERK1/2.	1
2491	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/@PROTEIN$ and Shc/Ras/ERK1/2.	1
2492	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/Ras/@PROTEIN$/2.	0
2493	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
2494	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2495	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2496	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
2497	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2498	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
2499	The large and diverse family of @PROTEIN$ monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	1
2500	The large and diverse family of cytochrome P450 monooxygenases (@PROTEIN$) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	0
2501	In 98.4% of all @PROTEIN$ sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the @COMPOUND$ center.	0
2502	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2503	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2504	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
2505	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
2506	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
2507	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
2508	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
2509	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
2510	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
2511	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of @PROTEIN$ lysines K4, K9, and @COMPOUND$-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	1
2512	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a GOD (@PROTEIN$) amperometric biosensor is employed for the glucose determination.	0
2513	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two @COMPOUND$ molecules, and a @PROTEIN$ (glucose oxidase) amperometric biosensor is employed for the glucose determination.	1
2514	The angiogenic potential of vascular endothelial growth factor (@PROTEIN$) and its @COMPOUND$ pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	1
2515	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
2516	Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
2517	Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
2518	Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0
2519	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
2520	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
2521	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (@PROTEIN$) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2522	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (MTHFR) and @PROTEIN$ (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2523	@COMPOUND$ deficiency due to the @PROTEIN$ (MTHFR) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
2524	@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1
2525	The bifunctional enzyme @PROTEIN$/N-acetylmannosamine kinase (GNE) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2526	The bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (@PROTEIN$) is the key enzyme for the biosynthesis of @COMPOUND$, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	1
2527	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2528	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
2529	4) PKA regulates neurotransmission without @PROTEIN$ involvement because, after @COMPOUND$ or CaC modulation of the PKC activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	0
2530	5) After PKA inhibition with H-89, @PROTEIN$ stimulation with @COMPOUND$ (or inhibition with CaC) does not lead to any change in evoked ACh release.	1
2531	In contrast, PKA inhibition prevent @PROTEIN$ stimulation (with the @COMPOUND$) and coupling to ACh output.	1
2532	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
2533	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
2534	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, @PROTEIN$ (CBG), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
2535	The present study investigated whether the levels of circulating @COMPOUND$ and its binding protein, corticosteroid binding globulin (@PROTEIN$), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	1
2536	Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0
2537	The influence of @COMPOUND$, atorvastatin and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
2538	The influence of simvastatin, @COMPOUND$ and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
2539	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2540	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
2541	Total plasma @COMPOUND$ level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.	0
2542	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and @COMPOUND$ levels were determined.	0
2543	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma @COMPOUND$ and cobalamin levels were determined.	0
2544	Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2545	Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
2546	Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0
2547	Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0
2548	The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1
2549	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from @PROTEIN$ followed by elevations in vascular smooth muscle (@COMPOUND$+))(i) levels and O(2)(.	0
2550	The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1
2551	Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1
2552	Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1
2553	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
2554	In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1
2555	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
2556	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
2557	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2558	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2559	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
2560	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
2561	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0
2562	This mutation in the @PROTEIN$ gene replaces a @COMPOUND$ encoding codon with a stop signal.	1
2563	New treatments for type 2 diabetes mellitus are needed to retain @PROTEIN$-@COMPOUND$ coupling and lower the risk of weight gain and hypoglycaemia.	1
2564	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2565	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
2566	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2567	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
2568	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2569	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2570	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
2571	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
2572	@PROTEIN$ alpha is a proximal mediator of synergistic hepatotoxicity from @COMPOUND$/lipopolysaccharide coexposure.	1
2573	A small cytoplasmic protein, @PROTEIN$, has been identified in human hepatic tissue, but its role in @COMPOUND$ metabolism is unknown.	0
2574	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
2575	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in @COMPOUND$-fed mice, and @PROTEIN$-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	0
2576	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by @PROTEIN$ (CYP7A1) protects against dyslipidemia and atherosclerosis.	1
2577	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by cholesterol 7alpha-hydroxylase (@PROTEIN$) protects against dyslipidemia and atherosclerosis.	1
2578	Therefore, we queried whether @COMPOUND$ is prosurvival in podocytes through a @PROTEIN$-dependent pathway.	0
2579	Treatment with pioglitazone, associated with @COMPOUND$, showed a reduction of @PROTEIN$ monocyte production after their in vitro activation with LPS.	1
2580	Regulation of T-type @PROTEIN$.1 channels expression by synthetic glucocorticoid @COMPOUND$ in neonatal cardiac myocytes.	1
2581	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
2582	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
2583	Role of @PROTEIN$ as a biomarker for predicting resistance to @COMPOUND$ in breast cancer.	1
2584	Acute regulation is mediated by the @PROTEIN$ (StAR), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2585	Acute regulation is mediated by the steroidogenic acute regulatory protein (@PROTEIN$), which facilitates the rapid influx of @COMPOUND$ into mitochondria, where P450scc resides.	1
2586	In the absence of @PROTEIN$ in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, @COMPOUND$.	0
2587	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of @PROTEIN$ in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, @COMPOUND$.	0
2588	When both the 17alpha-hydroxylase and 17,20 lyase activities of @PROTEIN$ are present in the zona reticularis, the androgen precursor @COMPOUND$ is produced.	1
2589	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of @PROTEIN$ (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2590	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and @PROTEIN$, and the low expression of 3beta-hydroxysteroid dehydrogenase (HSD3B2) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2591	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) result in the production of the large amounts of @COMPOUND$ that characterize adrenarche.	1
2592	These were mutated in onion @PROTEIN$ (acINV) according to the residue in festuca @COMPOUND$ : sucrose 1-fructosyltransferase (saSST) and vice versa.	0
2593	These were mutated in onion vacuolar invertase (acINV) according to the residue in festuca @COMPOUND$ : @PROTEIN$-fructosyltransferase (saSST) and vice versa.	0
2594	Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor @COMPOUND$ through @PROTEIN$ translocation.	1
2595	@COMPOUND$ converted unconjugated @PROTEIN$ (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1
2596	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (@PROTEIN$) to conjugated light chain 3 (LC3-II) and induced localization of LC3 to autophagosomes.	1
2597	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (@PROTEIN$) and induced localization of LC3 to autophagosomes.	1
2598	@COMPOUND$ converted unconjugated microtubule-associated protein light chain 3 (LC3-I) to conjugated light chain 3 (LC3-II) and induced localization of @PROTEIN$ to autophagosomes.	1
2599	@PROTEIN$ (AIF), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1
2600	Apoptosis inducing factor (@PROTEIN$), which plays a role in caspase-independent cell death, translocated to the nucleus in response to @COMPOUND$ treatment.	1
2601	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2602	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2603	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2604	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2605	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2606	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
2607	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, CycA, daclizumab, and @PROTEIN$, daily protein excretion and serum @COMPOUND$ increased.	0
2608	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, @PROTEIN$, daclizumab, and MMF, daily protein excretion and serum @COMPOUND$ increased.	0
2609	@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1
2610	An isocratic fluorescence HPLC assay for the monitoring of @PROTEIN$ activity and l-@COMPOUND$ depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	0
2611	Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
2612	Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
2613	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
2614	Effect of renin-angiotensin-@COMPOUND$ system inhibition, dietary sodium restriction, and/or diuretics on urinary @PROTEIN$ excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	0
2615	Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
2616	Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
2617	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2618	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2619	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2620	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2621	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2622	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2623	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2624	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2625	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2626	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2627	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
2628	ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0
2629	ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0
2630	Diabetes is characterized by elevated fasting blood @COMPOUND$ (FBG) resulting from improper @PROTEIN$ regulation and/or insulin resistance.	1
2631	THII significantly diminished these changes in @COMPOUND$ and @PROTEIN$.	0
2632	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2633	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2634	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2635	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2636	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2637	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
2638	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2639	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
2640	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
2641	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2642	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2643	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2644	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
2645	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
2646	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2647	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
2648	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2649	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
2650	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
2651	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
2652	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
2653	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
2654	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
2655	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
2656	@PROTEIN$, vascular endothelial growth factor, and @COMPOUND$ increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	0
2657	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2658	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2659	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
2660	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
2661	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
2662	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
2663	The 2-(acylamino)-3-thiophenecarboxylates suppressed @PROTEIN$-mediated @COMPOUND$ (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	1
2664	We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased @PROTEIN$ @COMPOUND$ after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.	1
2665	We found associations between the @COMPOUND$ phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of @PROTEIN$.	0
2666	@PROTEIN$ and free @COMPOUND$ are independent risk factors for benign prostatic hyperplasia.	0
2667	The objective of the present study was to test the @PROTEIN$, @COMPOUND$ and metabolic syndrome hypotheses as promoters of BPH.	0
2668	Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum @PROTEIN$ (beta=0.200, P=0.028), free @COMPOUND$ (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).	0
2669	@PROTEIN$ and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses.	0
2670	Insulin and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the @PROTEIN$ and the oestradiol hypotheses.	0
2671	@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0
2672	Much interest has been directed to the study of the @PROTEIN$, because @COMPOUND$ has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.	0
2673	In this study, we report a novel @PROTEIN$ defect in a Tunisian family, in which @COMPOUND$ 23 is substituted by a Stop codon causing a premature termination of translation.	1
2674	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0
2675	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2676	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2677	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
2678	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
2679	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
2680	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
2681	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
2682	In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1
2683	The effect of @COMPOUND$ (PN), a highly toxic agent, on @PROTEIN$ (CAT) activity in fish liver microsomal homogenates was determined.	1
2684	The effect of @COMPOUND$ (PN), a highly toxic agent, on catalase (@PROTEIN$) activity in fish liver microsomal homogenates was determined.	1
2685	NMR-derived @COMPOUND$-bound structure of @PROTEIN$ from the halophile Haloferax volcanii.	1
2686	These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
2687	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
2688	These results underscore the differential regulation of GPX expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
2689	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
2690	Effects of acceptor composition and mechanism of @PROTEIN$-mediated cellular free @COMPOUND$ efflux.	1
2691	Among the known mechanisms of reverse @COMPOUND$ transport (RCT), ATP binding cassette transporter G1 (@PROTEIN$)-mediated free cholesterol (FC) transport is the most recent and least studied.	1
2692	Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human @PROTEIN$ cDNA, which is inducible upon treatment with @COMPOUND$.	1
2693	@COMPOUND$ treatment significantly attenuated TNF-alpha, IL-6, and @PROTEIN$ 6 h after CLP.	1
2694	@COMPOUND$ treatment significantly attenuated TNF-alpha, @PROTEIN$, and IL-1beta 6 h after CLP.	1
2695	@COMPOUND$ treatment significantly attenuated @PROTEIN$, IL-6, and IL-1beta 6 h after CLP.	1
2696	@PROTEIN$ vesicles and red blood cells as carriers of @COMPOUND$ prior to oxygen for resuscitation after hemorrhagic shock in a rat model.	1
2697	@PROTEIN$ vesicles and red blood cells as carriers of carbon monoxide prior to @COMPOUND$ for resuscitation after hemorrhagic shock in a rat model.	1
2698	The purpose of this retrospective study was to compare the effects of @PROTEIN$ and @COMPOUND$ in the management of HIT.	0
2699	The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1
2700	Gene expression analysis revealed that the @PROTEIN$ gene encoding the outer membrane channel is essential for @COMPOUND$ tolerance in E. coli cells.	1
2701	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
2702	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
2703	Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1
2704	Postprandial @COMPOUND$ and @PROTEIN$.05) in HTAG.	0
2705	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1
2706	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1
2707	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
2708	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
2709	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0
2710	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
2711	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1
2712	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
2713	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and @PROTEIN$ were higher in @COMPOUND$-treated animals at this time-point.	1
2714	Complex modulation of L-type @COMPOUND$+) current inactivation by @PROTEIN$ in isolated rabbit cardiomyocytes.	1
2715	Models of noncoupled dinuclear @COMPOUND$ centers in @PROTEIN$.	1
2716	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
2717	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1
2718	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1
2719	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
2720	The models are significant because they maintain the existing type 1 (T1) @COMPOUND$, electron transfer site of @PROTEIN$ while including the second designed type 2 (T2) copper center that mimics the T2 catalytic sites in the target enzymes.	1
2721	The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
2722	The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
2723	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
2724	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
2725	Inhibition of human @PROTEIN$ by @COMPOUND$ and irreversible formation of advanced glycation end products.	1
2726	The affinity of @PROTEIN$ for gluconeogenic substrate @COMPOUND$ altered after preincubation with MG in the same manner, but less intensively.	1
2727	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
2728	Inhibition of rat liver @PROTEIN$ and L by the peptide aldehyde @COMPOUND$ and its analogues.	1
2729	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for cathepsin B and 163 nM for @PROTEIN$.	1
2730	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for @PROTEIN$ and 163 nM for cathepsin L.	1
2731	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the @COMPOUND$ moiety plays a key role in the interaction of this series of derivatives with @PROTEIN$ by acting as an anchor in its peripheral anionic site.	1
2732	Heme oxygenase-1 (@PROTEIN$) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
2733	@PROTEIN$ (HO-1) and @COMPOUND$ (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	0
2734	A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, @PROTEIN$-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
2735	A shift toward proinflammatory microglial activation is indicated by the release of @PROTEIN$, tumor necrosis factor-alpha, and @COMPOUND$ and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	0
2736	@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1
2737	The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1
2738	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
2739	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-@PROTEIN$ (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
2740	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (@PROTEIN$ 12 h) has not been characterized.	0
2741	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (V@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
2742	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0
2743	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0
2744	The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1
2745	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
2746	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
2747	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
2748	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
2749	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
2750	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0
2751	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1
2752	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1
2753	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine serum albumin (@PROTEIN$).	0
2754	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine @PROTEIN$ (BSA).	0
2755	Recognition of @COMPOUND$ components of pectin by @PROTEIN$.	1
2756	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin @COMPOUND$ to the recombinant form of human @PROTEIN$.	1
2757	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
2758	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
2759	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
2760	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
2761	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
2762	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
2763	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
2764	The binding of @COMPOUND$ to human @PROTEIN$ was used as the model system in order to evaluate the performance of automated SPME.	1
2765	@COMPOUND$ (NO) and interlukin-6 (@PROTEIN$) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	0
2766	Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0
2767	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
2768	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
2769	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
2770	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
2771	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
2772	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
2773	It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six @COMPOUND$ residues and a thiol ester-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0
2774	It is predicted to possess all the expected features of proPO members, including two putative @PROTEIN$ copper-binding motifs with six histidine residues and a @COMPOUND$-like motif, sharing 67% amino acid sequence identity with PmproPO1.	0
2775	Examination of @COMPOUND$-induced expression of the small heat shock protein gene, @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
2776	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (@PROTEIN$), HSP30, in Xenopus laevis A6 kidney epithelial cells.	1
2777	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (HSP), @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
2778	Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1
2779	Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1
2780	Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0
2781	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
2782	In this study we report the sequences of @PROTEIN$ cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to @COMPOUND$.	1
2783	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
2784	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1
2785	Surprisingly, no role of @PROTEIN$/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
2786	Surprisingly, no role of ERK1/2 or @PROTEIN$-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
2787	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1
2788	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1
2789	After intravenous administration of either DOTAP/@COMPOUND$ or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
2790	After intravenous administration of either DOTAP/cholesterol or @COMPOUND$/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
2791	After intravenous administration of either @COMPOUND$/cholesterol or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
2792	@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1
2793	Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0
2794	The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1
2795	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1
2796	Expression of @PROTEIN$ during germ cell apoptosis in testis of cynomolgus monkey after @COMPOUND$ and heat treatment.	0
2797	Comparing expression of @COMPOUND$ and @PROTEIN$ in testicular tissue from men with obstructive and nonobstructive azoospermia.	0
2798	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
2799	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
2800	Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1
2801	We evaluated the association between clinical outcome (safety and efficacy) of @COMPOUND$ monotherapy in metastatic breast cancer patients with @PROTEIN$ gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	1
2802	@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1
2803	DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1
2804	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (@PROTEIN$) inhibitor @COMPOUND$ or pharmacological inhibition of PKB.	1
2805	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitor @COMPOUND$ or pharmacological inhibition of @PROTEIN$.	0
2806	@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
2807	Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
2808	Molecular dynamics simulation techniques have been used to study the unbinding pathways of @COMPOUND$) from the ligand-binding pocket of the vitamin D receptor (@PROTEIN$).	1
2809	Activation of the Na+/K+-ATPase by @PROTEIN$ and @COMPOUND$ as a putative negative feedback mechanism in pancreatic beta-cells.	0
2810	Inhibiting @PROTEIN$ signalling in SUR1 (-/-) beta-cells blunted the @COMPOUND$-induced decrease of (Ca(2+))(c).	0
2811	In the mouse model of demyelination-remyelination induced by oral administration of @COMPOUND$, in situ hybridization showed an upregulation of the @PROTEIN$ gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	1
2812	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and @PROTEIN$) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
2813	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (@PROTEIN$), microglia (CD11b), or reactive glia (GFAP).	0
2814	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (@PROTEIN$).	0
2815	Cells positive for @PROTEIN$ mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	1
2816	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (OLIG2, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (@PROTEIN$), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
2817	Cells positive for DDR1 mRNA were also positive for oligodendrocyte markers (@PROTEIN$, @COMPOUND$, and APC) but not for markers of oligodendrocyte precursors (NG2), myelin markers (CNPase), microglia (CD11b), or reactive glia (GFAP).	0
2818	Therapeutic strategy to rescue mutation-induced exon skipping in @PROTEIN$ by adaptation of @COMPOUND$ snRNA.	1
2819	As a therapeutic strategy, @COMPOUND$ snRNAs were adapted to the novel @PROTEIN$ mutation and tested for its potential to reverse missplicing.	1
2820	Keeping @COMPOUND$ out of DNA: physiological role, structure and catalytic mechanism of @PROTEIN$.	1
2821	To prevent @COMPOUND$ incorporation into DNA, representatives of the dUTP nucleotidohydrolase (@PROTEIN$) enzyme family eliminate excess dUTP.	1
2822	The @PROTEIN$ binding pocket is highly specific for @COMPOUND$.	1
2823	@COMPOUND$ chain coordination involves Mg2+ and is analogous to that of @PROTEIN$.	1
2824	In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of @COMPOUND$ relies exclusively on @PROTEIN$ activity.	1
2825	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2826	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2827	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2828	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2829	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2830	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2831	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2832	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2833	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2834	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2835	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2836	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2837	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2838	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2839	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2840	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2841	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2842	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2843	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2844	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
2845	It controls the expression of a total of 11 genes, the @PROTEIN$ regulon, in a @COMPOUND$-dependent manner.	1
2846	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, @PROTEIN$, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
2847	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, @PROTEIN$, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
2848	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including @PROTEIN$-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
2849	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, ERK/@PROTEIN$, and Smads allows for integrated control by different neuroendocrine factors.	0
2850	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, @PROTEIN$/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
2851	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, @PROTEIN$, @COMPOUND$, NO, protein kinase A, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
2852	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, @PROTEIN$, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
2853	An enzymatic reaction between @COMPOUND$ and @PROTEIN$ produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	1
2854	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
2855	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
2856	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
2857	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
2858	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
2859	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
2860	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
2861	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
2862	These Ca2+-independent @PROTEIN$ display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains @COMPOUND$ functions.	0
2863	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-ERK 1/2 and phospho-@PROTEIN$ in the injured tissue.	1
2864	Effects of chronic inflammation and @COMPOUND$ tolerance on the expression of phospho-@PROTEIN$/2 and phospho-P38 in the injured tissue.	1
2865	The results of the present study show that @PROTEIN$ phosphorylation is unaltered by inflammation or @COMPOUND$ tolerance, each one individually, in the plantar tissue.	0
2866	In contrast, no significant differences in phospho-@PROTEIN$ expression were observed between naïve and tolerant animals acutely injected with saline or @COMPOUND$ in presence of CFA inflammation.	0
2867	These results suggest that @PROTEIN$ but not p38 could be implicated in the development of @COMPOUND$ tolerance during peripheral inflammation.	1
2868	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
2869	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
2870	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	1
2871	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
2872	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
2873	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	1
2874	A comprehensive literature review of clinical studies in children evaluating s-@PROTEIN$ or CysC-based formulas and plasma @COMPOUND$ or creatinine-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	0
2875	The comparison of s-@PROTEIN$ with plasma @COMPOUND$ indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	0
2876	S-@PROTEIN$ is most likely superior to plasma @COMPOUND$ and at least equal to creatinine-based formulas.	0
2877	@PROTEIN$-based prediction equations are at least as good as @COMPOUND$-based formulas but cannot replace exogenous methods.	0
2878	We examined the relationship between @PROTEIN$ and serum calcium, @COMPOUND$, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	0
2879	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS) in beta-cells.	1
2880	@PROTEIN$ was immunostained with mouse anti-FLAG primary antibody and @COMPOUND$-conjugated goat anti-mouse IgG secondary antibody.	1
2881	@PROTEIN$ is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate @COMPOUND$ level.	1
2882	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as methylenetetrahydrofolate reductase (@PROTEIN$).	1
2883	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as @PROTEIN$ (MTHFR).	1
2884	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by @PROTEIN$ (Con A)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
2885	We looked at the toxicity of non-drug-containing liposomes on (3)H-@COMPOUND$ incorporation by concanavalin A (@PROTEIN$)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	1
2886	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2887	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	1
2888	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2889	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2890	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2891	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2892	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2893	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2894	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2895	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
2896	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1
2897	This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1
2898	Suppression of @COMPOUND$-induced @PROTEIN$ 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.	1
2899	Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced @PROTEIN$ 2 expression in astrocytes by a novel @COMPOUND$ analog protects striatal neurons against apoptosis.	1
2900	The essential role of glucagon and @PROTEIN$ and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1
2901	The essential role of @PROTEIN$ and insulin and the importance of distributed control of @COMPOUND$ fluxes are highlighted in this review.	1
2902	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
2903	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2904	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
2905	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2906	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
2907	The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0
2908	The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0
2909	In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0
2910	@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0
2911	@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1
2912	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
2913	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
2914	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
2915	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
2916	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
2917	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
2918	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
2919	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
2920	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
2921	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
2922	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
2923	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
2924	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
2925	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
2926	Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
2927	Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
2928	A low plasma @PROTEIN$ @COMPOUND$ (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	1
2929	We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
2930	We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
2931	Decreased oral absorption of @COMPOUND$ after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-@PROTEIN$ to the first-pass metabolism in intestinal epithelial cells.	0
2932	The different mechanisms might be explained by the different sensitivity of @PROTEIN$ isoforms to Ca2+, @COMPOUND$+, and Ba2+.	1
2933	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
2934	Following @COMPOUND$ there was a time-dependent redistribution of total @PROTEIN$ from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	1
2935	The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1
2936	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
2937	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
2938	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
2939	In order to further analyse the protective mode of action, the superoxide anion scavenging activity of two extracts was evaluated in a @COMPOUND$/@PROTEIN$ system.	1
2940	In order to further analyse the protective mode of action, the @COMPOUND$ anion scavenging activity of two extracts was evaluated in a xanthine/@PROTEIN$ system.	0
2941	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
2942	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
2943	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
2944	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
2945	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for @PROTEIN$ and PAT1.	1
2946	Selenocystine is taken up well by the b(0,+) rBAT system, while @COMPOUND$ is a low-affinity substrate only for SIT1 and @PROTEIN$.	1
2947	Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1
2948	Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1
2949	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
2950	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
2951	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
2952	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
2953	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0
2954	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0
2955	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0
2956	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
2957	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1
2958	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1
2959	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
2960	Direct @PROTEIN$ (MR) activation with @COMPOUND$ has deleterious effects on the cerebral vasculature.	1
2961	Therefore, we hypothesized that systemic @PROTEIN$ inhibition with @COMPOUND$ (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.	1
2962	In this study, we attempted to evaluate the effects of @COMPOUND$ on F-@PROTEIN$ and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	1
2963	Consequently, @COMPOUND$-caused cytoskeletal interruption led to suppression of @PROTEIN$ expression and its metabolizing activity.	1
2964	Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1
2965	The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2966	The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2967	@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1
2968	The deduced amino acid sequence has 18 @COMPOUND$ residues, implying that S. henanense @PROTEIN$ binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	1
2969	Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM @COMPOUND$ resulted in parallel syntheses of NO and @PROTEIN$ as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	1
2970	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0
2971	These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1
2972	@PROTEIN$ (17beta-HSD1) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
2973	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is responsible for the catalytic reduction of the weak estrogen estrone (E1) into the highly potent @COMPOUND$ (E2).	1
2974	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, @COMPOUND$, norepinephrine, and in vitro-stimulated @PROTEIN$ production.	0
2975	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, @COMPOUND$, and in vitro-stimulated @PROTEIN$ production.	0
2976	Higher NF-kappaB stress responses were associated with lower @COMPOUND$ stress responses (beta=-.37, p=.05), higher pre-stress @PROTEIN$ production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	0
2977	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2978	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2979	TnBP (@COMPOUND$) and polysorbate 20 during the manufacture of the factor VIII/@PROTEIN$ concentrate Optivate has been investigated.	0
2980	A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1
2981	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
2982	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
2983	Membrane inlet mass spectrometry was used to observe @COMPOUND$ in the well-studied reaction of nitrite with @PROTEIN$.	1
2984	Diminished levels of L-arginine and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2985	Diminished levels of L-@COMPOUND$ and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2986	Diminished levels of L-arginine and endothelial nitric oxide synthase (@PROTEIN$) uncoupling through deficiency of @COMPOUND$ (BH(4)) may contribute to endothelial dysfunction.	1
2987	Diminished levels of L-@COMPOUND$ and endothelial @PROTEIN$ (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH(4)) may contribute to endothelial dysfunction.	0
2988	Serum testosterone, estradiol, sex hormone binding globulin (@PROTEIN$), and @COMPOUND$ levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
2989	Serum testosterone, @COMPOUND$, sex hormone binding globulin (@PROTEIN$), and dehydroepiandrosterone levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	0
2990	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-@COMPOUND$, LDL-cholesterol and @PROTEIN$ sensitivity (p=0.009 and p=0.002, respectively).	0
2991	A substrate regeneration cycle coupling @PROTEIN$ with l-@COMPOUND$ (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	0
2992	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (@COMPOUND$ m 1, Api m 4, and Api m 6) and two venom toxins (apamine and @PROTEIN$).	0
2993	The effect was lactose-inhibitable and required galectin-3 affinity for @COMPOUND$, a saccharide typically found on @PROTEIN$, since a mutant lacking this activity was without effect.	1
2994	The effect was lactose-inhibitable and required @PROTEIN$ affinity for @COMPOUND$, a saccharide typically found on cell surface glycoproteins, since a mutant lacking this activity was without effect.	1
2995	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
2996	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
2997	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2998	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
2999	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3000	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
3001	Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0
3002	Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
3003	Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
3004	Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0
3005	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
3006	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
3007	Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0
3008	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
3009	@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1
3010	@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1
3011	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
3012	Purification of an @PROTEIN$ involved in the conversion of methional to @COMPOUND$ in Oenococcus oeni IOEB 8406.	1
3013	Purification of an @PROTEIN$ involved in the conversion of @COMPOUND$ to methionol in Oenococcus oeni IOEB 8406.	1
3014	An @COMPOUND$ (P)H-dependent @PROTEIN$ involved in the reduction of methional was then purified to homogeneity.	1
3015	An NAD (P)H-dependent @PROTEIN$ involved in the reduction of @COMPOUND$ was then purified to homogeneity.	1
3016	Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing @COMPOUND$ (P)H-dependent @PROTEIN$.	1
3017	The purified @PROTEIN$ does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile @COMPOUND$ during MLF.	0
3018	The function of the purified @PROTEIN$ remains unclear, although the role of the sulfur atom in @COMPOUND$ molecules in the interaction between enzyme and substrate was evidenced.	0
3019	The function of the purified @PROTEIN$ remains unclear, although the role of the @COMPOUND$ in methional molecules in the interaction between enzyme and substrate was evidenced.	0
3020	All strains tested positive for @PROTEIN$ activity while none where capable of @COMPOUND$ degradation.	0
3021	Addition of SOD (@PROTEIN$) doubled the amount of @COMPOUND$ detected.	1
3022	Addition of @PROTEIN$ (superoxide dismutase) doubled the amount of @COMPOUND$ detected.	1
3023	Drug-resistant cancer cells became sensitive to @COMPOUND$ treatment when @PROTEIN$ was expressed in cytosol.	1
3024	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1
3025	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1
3026	We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1
3027	Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1
3028	@COMPOUND$ enhances the activity of nuclear factor-kappaB pathway through @PROTEIN$ and BLT2 receptors in atherosclerosis.	1
3029	@PROTEIN$ activity and total nitrite and @COMPOUND$ concentrations in serum: novel biochemical markers for type 2 diabetes.	0
3030	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3031	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
3032	Serum lipid, creatinine, @COMPOUND$, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3033	Serum lipid, @COMPOUND$, uric acid, @PROTEIN$, HbA(1C) and urinary albumin concentration were measured.	0
3034	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
3035	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, @PROTEIN$ (PCNA) and cleaved caspase-3.	0
3036	Ulcerated tissues were processed to assess ulcer area, @COMPOUND$, proliferating cell nuclear antigen (@PROTEIN$) and cleaved caspase-3.	0
3037	This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of @PROTEIN$ regulation, and the reciprocal relationship between NHE3 and NHE8 at the lumen of the proximal tubule.	0
3038	This article discusses the physiology of proximal @COMPOUND$ (+)/H(+) exchange, the multiple mechanisms of NHE3 regulation, and the reciprocal relationship between NHE3 and @PROTEIN$ at the lumen of the proximal tubule.	0
3039	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3040	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3041	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
3042	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
3043	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3044	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3045	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3046	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3047	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3048	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3049	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3050	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
3051	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3052	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
3053	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3054	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
3055	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
3056	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
3057	Streptokinase (SK), @PROTEIN$ (GOx) and @COMPOUND$ (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with glucose sensing properties.	0
3058	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0
3059	Our data suggest that @PROTEIN$ translocates to the contractile system and anchors to TnI in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1
3060	Our data suggest that PKCalpha translocates to the contractile system and anchors to @PROTEIN$ in a @COMPOUND$+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	1
3061	In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1
3062	Mutagenesis studies confirm the critical role of the @COMPOUND$-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for @PROTEIN$ activity.	1
3063	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3064	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
3065	Previous studies have suggested a regulatory relationship between serum @COMPOUND$, vitamin D, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
3066	Previous studies have suggested a regulatory relationship between serum phosphorus, @COMPOUND$, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
3067	This condition is caused by mutations in the PTH/@PROTEIN$ receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3068	This condition is caused by mutations in the @PROTEIN$/PTHrP receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
3069	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating @COMPOUND$ and lipid metabolism and controlling energy homeostasis in @PROTEIN$-sensitive tissues.	0
3070	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
3071	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
3072	Expression of @COMPOUND$ : @PROTEIN$ in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	0
3073	@COMPOUND$ : @PROTEIN$ (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	1
3074	Intrinsic fluorescence of @COMPOUND$-214 in @PROTEIN$ was monitored upon addition of the chemicals.	1
3075	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
3076	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
3077	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
3078	The metal-@COMPOUND$ connectivity of recombinant Cd(7)-MT10 @PROTEIN$ from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.	1
3079	Radical scavenging activity of lipophilized products from @PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids.	1
3080	Lipase-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized @PROTEIN$ from Candida antarctica (E.C.	1
3081	@PROTEIN$-catalyzed transesterification of @COMPOUND$ with cinnamic and ferulic acids using an immobilized lipase from Candida antarctica (E.C.	1
3082	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1
3083	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
3084	The study established that SPZ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of @COMPOUND$ bioavailability and tissue oxygenation.	1
3085	The study established that @COMPOUND$ attenuated myocardial I/R injury through overexpression of @PROTEIN$, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.	1
3086	Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1
3087	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
3088	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces @PROTEIN$-stimulated PKB activation and @COMPOUND$ uptake.	0
3089	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces insulin-stimulated @PROTEIN$ activation and @COMPOUND$ uptake.	0
3090	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
3091	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
3092	Functional @PROTEIN$ is not required for macrophage @COMPOUND$ efflux to human serum.	0
3093	The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from @COMPOUND$, but not the @PROTEIN$ that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.	0
3094	In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular @PROTEIN$ of LN229 cells exceeded that of the previous designed lead compound @COMPOUND$.	1
3095	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
3096	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3097	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
3098	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or @COMPOUND$+)-dependent processes; it was lost after patch excision or after membrane cholesterol depletion but was restored after cholesterol reconstitution.	0
3099	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, @PROTEIN$, or Ca(2+)-dependent processes; it was lost after patch excision or after membrane @COMPOUND$ depletion but was restored after cholesterol reconstitution.	0
3100	Modulation of Rac1 activity by @COMPOUND$/@PROTEIN$ regulates pulmonary endothelial barrier function.	0
3101	Modulation of @PROTEIN$ activity by @COMPOUND$/DDAH regulates pulmonary endothelial barrier function.	1
3102	Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of @PROTEIN$ 1 (OVGP1).	0
3103	Endometriosis is associated with @COMPOUND$ resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of oviductal glycoprotein 1 (@PROTEIN$).	1
3104	In this study we evaluated @PROTEIN$ and steroid receptor expression in oviducts of baboons with endometriosis during the midsecretory phase and determined whether @COMPOUND$ resistance associated with endometriosis also occurs in the oviduct.	1
3105	These data imply that the normal antagonism of @COMPOUND$ on ESR and @PROTEIN$, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	1
3106	These data imply that the normal antagonism of @COMPOUND$ on @PROTEIN$ and OVGP1, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	1
3107	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either @COMPOUND$, perindopril, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3108	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, @COMPOUND$, or hydralazine while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3109	Transgenic mice that overexpress rat @PROTEIN$ in their proximal tubule cells were given either apocynin, perindopril, or @COMPOUND$ while untreated or apocynin-treated non-transgenic littermates served as controls.	0
3110	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased @COMPOUND$ uptake rate was found suggesting an upregulation of @PROTEIN$ number in response to a history of high cocaine intake.	1
3111	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3112	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3113	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3114	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and @PROTEIN$, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3115	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, glutamate transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3116	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, @PROTEIN$, @COMPOUND$ transport and GluRs, BDNF and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3117	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, glutamate transport and GluRs, BDNF and TrkB, numerous @PROTEIN$ family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and @COMPOUND$ generation.	0
3118	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, HINT1, @COMPOUND$ transport and GluRs, @PROTEIN$ and TrkB, numerous 14-3-3 protein family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and ATP generation.	0
3119	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, @PROTEIN$, BDNF and VGF), and MAP kinase pathways.	0
3120	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, @PROTEIN$ and VGF), and MAP kinase pathways.	0
3121	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, BDNF and @PROTEIN$), and MAP kinase pathways.	0
3122	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
3123	Recent studies have suggested that a decrease in the specific activity of the 2-@PROTEIN$ complex (ODHC) is important for @COMPOUND$ overproduction by Corynebacterium glutamicum.	1
3124	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating @COMPOUND$ residue with glycine, alanine, and cysteine.	0
3125	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, @COMPOUND$, and cysteine.	0
3126	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with @COMPOUND$, alanine, and cysteine.	0
3127	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, alanine, and @COMPOUND$.	0
3128	Two crystal structures of the H60C_ @PROTEIN$ in complex with @COMPOUND$ and histamine were solved to 1.7- and 1.96-A resolution, respectively.	1
3129	Two crystal structures of the H60C_ @PROTEIN$ in complex with imidazole and @COMPOUND$ were solved to 1.7- and 1.96-A resolution, respectively.	1
3130	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that heme-@COMPOUND$ coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0
3131	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that @COMPOUND$-thiolate coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0
3132	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of lysyl oxidase and @PROTEIN$ mRNA expression.	1
3133	Real-time polymerase chain reaction analysis of hypoxic, NO-@COMPOUND$ treated PC-3 cells showed downregulation of @PROTEIN$ and carbonic anhydrase IX mRNA expression.	1
3134	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and @COMPOUND$ intolerance occur in the setting of @PROTEIN$ resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	1
3135	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
3136	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
3137	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
3138	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
3139	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1
3140	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3141	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
3142	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
3143	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
3144	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
3145	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
3146	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (@PROTEIN$) and @COMPOUND$ response to this test that normalizes gradually during successful antidepressant therapy.	0
3147	We examined plasma @PROTEIN$ and @COMPOUND$ responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	0
3148	Identification of Aldh1a, @PROTEIN$ and RAR orthologs in protostomes pushes back the @COMPOUND$ genetic machinery in evolutionary time to the bilaterian ancestor.	1
3149	We have also described LD between @PROTEIN$ alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
3150	We have also described LD between HLA-G alleles and HLA class II @PROTEIN$ allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
3151	@COMPOUND$ oligonucleotide-induced expression of truncated @PROTEIN$ in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	1
3152	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0
3153	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
3154	Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
3155	Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
3156	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0
3157	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0
3158	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
3159	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
3160	To examine the relationship of functional expression of @PROTEIN$ to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and @COMPOUND$ on Southwest Oncology Group trials.	0
3161	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1
3162	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1
3163	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1
3164	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1
3165	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1
3166	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1
3167	To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0
3168	To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
3169	To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
3170	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3171	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
3172	Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1
3173	The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0
3174	Curcuminoids inhibited @PROTEIN$ in the in-vitro assay with IC(50) value of 19.67, @COMPOUND$ 16.84, demethoxycurcumin 33.14 and curcumin 67.69 microM.	1
3175	Pharmacological stimulation of @PROTEIN$ channels with @COMPOUND$ (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	1
3176	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1
3177	Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1
3178	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1
3179	The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
3180	The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
3181	Finally, we provided evidence for @COMPOUND$ as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of @PROTEIN$ channels modulating glutamate but not GABA release.	1
3182	With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1
3183	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3184	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3185	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3186	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
3187	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0
3188	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for @PROTEIN$, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
3189	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated @PROTEIN$ secretion in pancreatic beta-cells.	1
3190	Regulatory roles for @PROTEIN$, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
3191	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a @PROTEIN$, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
3192	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for Rac1, a small G-protein, in @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS).	1
3193	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for @PROTEIN$, a small G-protein, in @COMPOUND$-stimulated insulin secretion (GSIS).	0
3194	@COMPOUND$-bound form) and membrane association of @PROTEIN$ in INS 832/13 cells and rat islets.	0
3195	Interestingly, however, in contrast to the inhibitory effects of @COMPOUND$, @PROTEIN$ gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	0
3196	This vector allows the co-expression of alpha-Hb as a fusion protein with @PROTEIN$ (GST-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
3197	This vector allows the co-expression of alpha-Hb as a fusion protein with Glutathione S-Transferase (@PROTEIN$-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
3198	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3199	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3200	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3201	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3202	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3203	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3204	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3205	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3206	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
3207	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
3208	The erythrocyte @PROTEIN$ activity was higher in @COMPOUND$ group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.	1
3209	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
3210	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
3211	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
3212	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
3213	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3214	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
3215	Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, @COMPOUND$ and @PROTEIN$.	0
3216	Sympathetic neurogenic Ca2+ signalling in rat arteries: @COMPOUND$, noradrenaline and @PROTEIN$.	0
3217	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required ATP or @COMPOUND$.	1
3218	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required ATP or @COMPOUND$.	1
3219	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required @COMPOUND$ or dATP.	1
3220	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required @COMPOUND$ or dATP.	1
3221	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential @COMPOUND$ residues but only when coexpressed with the @PROTEIN$.	0
3222	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
3223	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
3224	Liver @COMPOUND$ DNA adducts and acrylamide and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3225	Liver glycidamide DNA adducts and acrylamide and glycidamide N-terminal @COMPOUND$ @PROTEIN$ adducts were also determined.	1
3226	Liver glycidamide DNA adducts and @COMPOUND$ and glycidamide N-terminal valine @PROTEIN$ adducts were also determined.	0
3227	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
3228	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
3229	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3230	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
3231	Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1
3232	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1
3233	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1
3234	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1
3235	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
3236	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
3237	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, tumor necrosis factor-alpha (@PROTEIN$), and @COMPOUND$ (NO).	0
3238	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester), in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, @PROTEIN$-alpha (TNF-alpha), and @COMPOUND$ (NO).	0
3239	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and @PROTEIN$ with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3240	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing @PROTEIN$ and cytochrome c with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
3241	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as @PROTEIN$, nitrite/nitrate, glutathione peroxidase and @COMPOUND$ were performed.	0
3242	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as superoxide dismutase, nitrite/nitrate, @PROTEIN$ and @COMPOUND$ were performed.	0
3243	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
3244	These results indicate that cloned embryos have aberrant DNA methylation in the @COMPOUND$ sites of the PE region of @PROTEIN$, and this may contribute directly to abnormal expression of this gene in cloned embryos.	1
3245	Xenopus follicle-enclosed oocytes are endowed with @PROTEIN$ located in the follicular cell membrane ; their stimulation by @COMPOUND$ elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	1
3246	Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1
3247	The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1
3248	Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1
3249	Here we show the first direct quantitative evidence for @PROTEIN$ binding to the cap analog @COMPOUND$.	1
3250	van't Hoff analysis of @COMPOUND$-@PROTEIN$ equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	1
3251	eIFiso4G was shown to enhance the interaction of @PROTEIN$ with @COMPOUND$ cap analog by 2.4-fold.	1
3252	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1
3253	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3254	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1
3255	In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
3256	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1
3257	In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1
3258	@COMPOUND$ (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human @PROTEIN$ (P450) enzymes.	1
3259	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
3260	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
3261	Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1
3262	Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0
3263	A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0
3264	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of @COMPOUND$ and @PROTEIN$, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	0
3265	Combination of @PROTEIN$ and @COMPOUND$ further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	0
3266	@PROTEIN$ and @COMPOUND$ combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	0
3267	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0
3268	Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1
3269	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1
3270	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1
3271	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding @PROTEIN$ (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3272	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (@PROTEIN$), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3273	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and @PROTEIN$ (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3274	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (@PROTEIN$), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3275	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (@PROTEIN$) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
3276	Furthermore, we study the @PROTEIN$ activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor @COMPOUND$.	0
3277	@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1
3278	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3279	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3280	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3281	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
3282	Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1
3283	Atypical sialylated N-@COMPOUND$ structures are attached to neuronal @PROTEIN$.	1
3284	@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1
3285	No regional difference in @PROTEIN$ occupancy by the second-generation antipsychotic drug @COMPOUND$ in humans: a positron emission tomography study.	1
3286	In this study, regional distribution of @PROTEIN$ occupancy by @COMPOUND$ was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.	1
3287	Striatal and extrastriatal @PROTEIN$ binding @COMPOUND$, respectively.	0
3288	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3289	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3290	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3291	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3292	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
3293	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
3294	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in @COMPOUND$ phosphorylation of @PROTEIN$ (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	1
3295	A significant decrease was observed in GABA (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
3296	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	0
3297	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
3298	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
3299	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
3300	A significant decrease was observed in @COMPOUND$ (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
3301	Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (@PROTEIN$) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
3302	Extensive neutrophil infiltration and chemoattractant factor @PROTEIN$ (IL-8) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
3303	In addition, increased signal transducer and activator of transcription factors (@PROTEIN$) 1 and STAT3 were observed in @COMPOUND$ treated IL-10 KO mice.	1
3304	In addition, increased signal transducer and activator of transcription factors (STAT) 1 and @PROTEIN$ were observed in @COMPOUND$ treated IL-10 KO mice.	1
3305	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3306	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (@PROTEIN$), catalase and glucose-6-phosphate dehydrogenase.	0
3307	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3308	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of @PROTEIN$ (SOD), catalase and glucose-6-phosphate dehydrogenase.	0
3309	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of glutathione (@COMPOUND$), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3310	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of @COMPOUND$ (GSH), activity of superoxide dismutase (SOD), @PROTEIN$ and glucose-6-phosphate dehydrogenase.	0
3311	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
3312	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1
3313	A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated @PROTEIN$ (AMPK).	1
3314	A single bout of exercise increases @COMPOUND$ uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated protein kinase (@PROTEIN$).	1
3315	Changes in @COMPOUND$ consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-@PROTEIN$-DN and WT.	0
3316	@PROTEIN$-mediated @COMPOUND$ efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	1
3317	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS).	1
3318	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$).	1
3319	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS).	1
3320	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS).	1
3321	Effects of DHT on COX-2 and @PROTEIN$ were attenuated by @COMPOUND$.	0
3322	Effects of @COMPOUND$ on COX-2 and @PROTEIN$ were attenuated by flutamide.	1
3323	Effects of DHT on @PROTEIN$ and iNOS were attenuated by @COMPOUND$.	0
3324	Effects of @COMPOUND$ on @PROTEIN$ and iNOS were attenuated by flutamide.	1
3325	In conclusion, activation of the NFkappaB-mediated COX-2/@PROTEIN$ pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
3326	In conclusion, activation of the NFkappaB-mediated @PROTEIN$/iNOS pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
3327	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
3328	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
3329	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
3330	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
3331	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
3332	Reactive oxygen species induce phosphorylation of @COMPOUND$ 118 and 167 on @PROTEIN$ alpha.	1
3333	Both kinases have been implicated in the phosphorylation of @COMPOUND$ 118 and serine 167 on @PROTEIN$, respectively.	1
3334	Our data show for the first time that ROS can induce post-translational modifications of @PROTEIN$ at @COMPOUND$ 118 and serine 167, and may lead to ERalpha down-regulation in human breast cancer cells.	1
3335	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by @PROTEIN$ inhibition or @COMPOUND$ chemotherapy.	0
3336	Expression of the @PROTEIN$-GFP fusion protein was observed exclusively upon @COMPOUND$ induction and was uniformly distributed throughout the intestinal epithelium.	1
3337	@PROTEIN$ is an important neuronal calcium sensor (NCS) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
3338	Recoverin is an important neuronal calcium sensor (@PROTEIN$) protein, which have been implicated in a wide range of @COMPOUND$+) signaling events in neurons and photoreceptors.	1
3339	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
3340	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
3341	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
3342	@PROTEIN$ promoter hypermethylation correlates with a survival benefit from @COMPOUND$ in patients with recurrent anaplastic astrocytoma but not glioblastoma.	1
3343	To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (@PROTEIN$) promoter methylation and benefit from @COMPOUND$ in patients with recurrent high-grade glioma.	1
3344	Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1
3345	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
3346	This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
3347	Deletion of the first @COMPOUND$-rich region of the varicella-zoster virus @PROTEIN$ ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	1
3348	The data provide the first demonstration for the presence of @PROTEIN$ in primary cilia of renal epithelial cells, and a functional @COMPOUND$-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	0
3349	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
